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Federal Funds for Syringe Exchange Programs:
A Necessary Component Toward Achieving an
AIDS-Free Generation
Rachel L. Hulkower* & Leslie E. Wolf*
I. INTRODUCTION
In November 2011, then U.S. Secretary of State Hillary Clinton declared:
"The goal of an AIDS-free generation may be ambitious, but it is possible
with the knowledge and interventions we have right now."' In advance of
World AIDS Day 2012, the U.S. Department of State expanded on that vision
with its publication, "PEPFAR Blueprint: Creating an AIDS-free
Generation." It described the Blueprint as a "policy imperative:" "The
United States believes that by making smart investments based on sound
science, and a shared global responsibility, we can save millions of lives and
achieve an AIDS-free generation." 2 Ironically, U.S. policy forbids
investment in one prevention measure with strong evidence of
effectiveness-needle and syringe exchange programs ("SEPs").3 As a result,
the Blueprint fails to discuss strategies for reducing human
immunodeficiency virus ("HIV") transmission among injecting drug users
("IDUs"), undermining the ability to achieve the underlying goal of an AIDSfree generation.
The federal ban on funding for SEPs is generally consistent with U.S. drug
policy, rooted in President Richard Nixon's 1971 "War on Drugs." In
response to the growing drug epidemic affecting the United States, President
Nixon signed into law the Controlled Substances Act of 1970,' which created
classifications of controlled substances and delegated enforcement power to

J.D., Georgia State University College of Law.
Professor of Law, Georgia State University College of Law, Center for Law, Health &
Society.
1. Hillary Clinton, United States Sec'y of State, Remarks on Creating an AIDS-free
Generation at National Institutes of Health (Nov. 8, 2011), available at http://www.state.
gov/secretary/rm/2011/11/176810.htm.
2. U.S. DEP'T OF STATE, PEPFAR BLUEPRINT: CREATING AN AIDS-FREE GENERATION 5
(2012), available at http://www.pepfar.gov/documents/organization/201386.pdf.
3. See discussion infra Part II.
4. See Controlled Substances Act of 1970, Pub. L. No. 91-513, 84 Stat. 1242
(codified at 21 U.S.C. §§ 801-904 (2012)).
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the Attorney General. Nixon then established the Drug Enforcement
Administration in 1973 to enforce federal laws and to consolidate many
organizations already attempting to combat drug use.' Nixon's "War on
Drugs," continued by subsequent administrations, employs a punitive
approach that treats drug users as criminals for possessing and using drugs
and drug paraphernalia.7 The approach has been largely unsuccessful: forty
years later, drug abuse remains a pervasive and important problem.8
The punitive model persists and negatively impacts efforts to prevent HIV
transmission among IDUs in several ways. 9 It erects barriers to access clean
needles and syringes that make it challenging for IDUs to follow prevention
measures. Its imposition of criminal penalties may inhibit IDUs from
admitting their drug use, which gives rise to their HIV risk, and, thus, from
getting accurate prevention information and help. This model predates the
Acquired Immune Deficiency Syndrome ("AIDS") epidemic, caused by
HIV, which was first recognized in the U.S. in five men originally diagnosed
with pneumonia in 1981.0 Since then, more than half a million people have
died from AIDS in the U.S. alone," and more than one million are living with
5. Id. §§ 812, 871.
6. Thirty Years of America's Drug War, FRONTLINE, http://www.pbs.org/wgbh/
pages/frontline/shows/drugs/cron/ (last visited Mar. 4, 2013).
7. President Richard Nixon first introduced the phrase "War on Drugs" in the 1970s. The
effort instigated decades of stringent drug laws largely enforced against drug users rather than
transporters and distributors. The "War on Drugs" is now considered to have failed at
preventing illicit drug use. GLOBAL COMM'N ON DRUG POLICY, WAR ON DRUGS: A REPORT OF
THE GLOBAL COMMISSION ON DRUG POLICY 4 (2011); Amy Windham, Zero Tolerance, in 4
ENCYCLOPEDIA OF DRUGS, ALCOHOL, AND ADDICTIVE BEHAVIOR 317-18 (3d ed. 2008).
8. In 2011 alone, the FBI reported over 1.5 million arrests for drug abuse violations.
Uniform Crime Reports: Estimated Number of Arrests, United States, 2011, FED. BUREAU OF
INVESTIGATION, http://www.fbi.gov/about-us/cjis/ucr/crime-in-the-u.s/2011/crime-in-the-u.s.201 1/tables/table-29 (last visited Mar. 4, 2013).
9. INT'L FED'N OF RED CROSS & RED CRESCENT SOCIETIES, SPREADING THE LIGHT OF
SCIENCE 1 (2003). According to International Federation of Red Cross and Red Crescent
Societies President Juan Manuel Suarez del Toro Rivero, "political imperatives, donor
demands, and ignorance and fear continue to impede the work of preventing and alleviating
suffering and protecting human dignity." Id.
10. See M. S. Gottlieb et al., Pneumocystis Pneumonia Los Angeles, 30 MORBIDITY &
MORTALITY WKLY. REP. 1 (1981).
11.
CTRS. FOR DISEASE CONTROL & PREVENTION, HIV SURVEILLANCE REPORT:
DIAGNOSES OF HIV INFECTION AND AIDS IN THE UNITED STATES AND DEPENDENT AREAS,
2008, at 69 (2010), available at http://www.cdc.gov/hiv/surveillance/resources/reports
/2008report/pdf/2008SurveillanceReport.pdf; NAT'L INST. OF ALLERGY & INFECTIOUS
DISEASES, U.S. DEP'T OF HEALTH & HUMAN SERVS., UNDERSTANDING THE IMMUNE SYSTEM:
How IT WORKS 33, 48 (2007), available at http://www.niaid.nih.gov/topics/immuneSystem!
Documents/theimmunesystem.pdf; Ctrs. for Disease Control & Prevention, Thirty Years of
HIV 1981-2011, 60 MORBIDITY & MORTALITY WKLY. REP. 689 (2011) [hereinafter CDC,
Thirty Years of HIV]. HIV causes AIDS by destroying cells in the body that make up and
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HIV.1 2 Injecting drug use is a pervasive mode of HIV transmission that
accounts for 18% of males and 32% of females living with HIV in the United
States.' 3 After men who have sex with men, IDUs have the second largest
rate of HIV transmission. 4
The Centers for Disease Control and Prevention ("CDC") recommends
that IDUs cease drug use altogether because sharing used needles and
syringes or preparation equipment increases the chance of HIV transmission
between IDUs." However, public health organizations including CDC, the
American Foundation for AIDS Research ("amFAR"), and the World Health
Organization ("WHO") have found that a comprehensive approach to
substance abuse prevention, HIV treatment, and access to clean, sterile
syringes can curb the rate of new HIV infections among IDUs.16 While
eliminating injecting drug use is the most effective HIV prevention strategy,
SEPs are a valuable means for preventing the spread of HIV among IDUs.'"
operate the human immune system, thus removing the body's primary disease barrier and
making it easy for opportunistic diseases to cause infection. NAT'L INST. OF ALLERGY &

INFECTIOUS DISEASES, supra, at 33; see also How HIV Causes AIDS, NAT'L INST. OF ALLERGY
&
INFECTIOUS
DISEASES,
http://www.iaid.nih.gov/topics/hivaids/understanding/

howhivcausesaids/Pages/cause.aspx (last updated Apr. 3, 2012).
12. CDC, Thirty Years of HIV, supra note 11; Lucian Torian et al., HIV SurveillanceUnited States, 1981-2008, 60 MORBIDITY & MORTALITY WKLY. REP. 689 (2011). As of 2009,

there remain 1,178,350 people in the United States living with HIV. Id. In the United States
alone, a total of 594,495 people have died from AIDS since it was discovered in 1981.
Injecting drugs users account for the lowest proportion of HIV-positive individuals surviving
twelve, twenty-four, and thirty-six months after diagnosis. 21 CTRS. FOR DISEASE CONTROL &
PREVENTION, HIV SURVEILLANCE REPORT: DIAGNOSES OF HIV INFECTION AND AIDS IN THE

UNITED

STATES

AND

DEPENDENT

AREAS,

2009,

at

10,

46

(2011),

available

at

http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/pdf/2009SurveillanceRep
ort.pdf [hereinafter CDC, DIAGNOSES 2009]. While the number of new diagnoses of HIV
remained stable between 2006 and 2009 at a rate of 17.4 persons per 100,000, there may be a
decreasing trend in infections attributed to injecting drug use. Id. at 6-7.
13.

CDC, DIAGNOSES 2009, supra note 12, at 10. The transmission categories commonly

used to study HIV/AIDS transmission and prevention are different for male and female adults.
Male transmission categories include male-to-male sexual contact, injecting drug use, maleto-male sexual contact and injecting drug use, heterosexual contact, and other. Female
transmission categories include injecting drug use, heterosexual contact, and other. Id. at 34.
14. Div. of HIV/AIDS Prevention, Ctrs. for Disease Control & Prevention, AIDS
Associated with Injecting-Drug Use-United States, 1995, 45 MORBIDITY & MORTALITY

WKLY. REP. 392 (1996) [hereinafter Div. of HIV/AIDS Prevention, AIDS Associated with
Injecting-Drug Use]; Dennis H. Osmond, Epidemiology of HIV/AIDS in the United States,
HIV INSIT (Mar. 2003), http://hivinsite.ucsf.edu/insite?page=kb-0 1-03.
15.

Access to Sterile Syringes, CTRS. FOR DISEASE CONTROL & PREVENTION (Dec. 2005),

http://www.cdc.gov/idu/facts/aed idu acc.htm; see also Don C. Des Jarlais et al., Doing
Harm Reduction Better: Syringe Exchange in the United States, 104 ADDICTION 1441 (2009).
16.

Syringe Exchange Programs, CTRS. FOR DISEASE CONTROL & PREVENTION (Dec.

2005), http://www.cdc.gov/idu/facts/aed idu syr.pdf.
17. Questions and Answers: HIV Prevention, CTRS. FOR DISEASE CONTROL &
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Providing access to sterile syringes and needles through SEPs is
controversial because it conflicts with the U.S. drug policy.'" Some
organizations and politicians oppose SEPs out of fear that they merely
encourage IDUs to continue their risky behavior and that the programs will
increase the number of syringes found in the streets.' 9 Although research has
debunked most of these concerns, 20 SEPs have been slow to gain national
support. 2 ' In 1988, Congress banned the use of federal funds for SEPs. This

http://www.cdc.gov/hiv/resources/qa/prevention.htm#2 (last modified Oct. 20,
2006).
18. Des Jarlais et al., supra note 15, at 1441. Injecting drug users are often labeled as
criminals, rather than people with mental or physical illness. This stigma creates significant
barriers that hinder societal support for SEP operations. Barbara Tempalski et al., Social and
Political Factors Predicting the Presence of Syringe Exchange Programs in 96 US
Metropolitan Areas, 97 AM. J. PUB. HEALTH 437, 437-38 (2007). Where politics have
historically slowed the response to public health issues, social movements have often sparked
the creation of necessary health policy. Id. at 437. However, because this issue involves illicit
drugs and drug users, some drug prevention entities oppose SEPs, while HIV prevention
organizations support them. See id. Former President George H.W. Bush's Chief of Drug
Policy argued that such programs "undercut[] the credibility of society's message that drug
use is illegal and morally wrong." Bob Egelko, U.S. Ends Funding Ban for Needle Exchanges,
PREVENTION,

S.F. CHRON., Dec. 18, 2009, at A126.

19. Denise Paone et al., Syringe Exchange: HIV Prevention, Key Findings, and Future
Directions, 30 INT'L J. ADDICTION 1647 (1995); Ban Lifted on Federal Funding for Needle
Exchange, (Nat'l Pub. Radio Dec. 18, 2009), http://www.npr.org/templates/transcript/
transcript.php?storyld=121511681 (reporting that those criticizing the modification to the ban
fear that doing so provides incentives to continue use). Opposition to SEP operation comes
from many places. Many state statutes include hypodermic syringes and needles in their
definition of prohibited "drug paraphernalia," creating legal opposition to SEPs. Tempalski et
al., supra note 18, at 438. Law enforcement, politicians, and other policy makers also oppose
SEPs. Id. Religious and neighborhood organizations and business associations create
opposition from within the communities where SEPs operate. Id.
20. Access to Sterile Syringes, supra note 15 ("Ensuring access to sterile syringes does
not increase the number of persons who inject drugs or the number of drug injections. It does
reduce the sharing and reuse of syringes."). Studies evaluating the effectiveness of syringe and
needle exchange generally demonstrate a reduction in risky behaviors such as needle sharing
or reusing and a decrease in frequency of injecting drug use. COMM. ON THE PREVENTION OF
HIV INFECTION AMONG INJECTING DRUG USERS IN HIGH-RISK COUNTRIES, INST. OF MED.,

Sterile Needle and Syringe Access, and Outreach and Education, in PREVENTING HIV
INFECTION AMONG INJECTING DRUG USERS IN HIGH RISK COUNTRIES: AN ASSESSMENT OF THE

EVIDENCE 137, 141-44 (2006). Drug-related arrests should increase if the introduction of an
SEP into a community actually resulted in an increase in crime; however, the rate of drugrelated arrests remains the same. Melissa A. Marx et al., Trends in Crime and the Introduction
of a Needle Exchange Program, 90 AM. J. OF PUBLIC HEALTH 1933, 1934 (2000). The

instances of resisting arrest are used to measure an IDU's perception of "lawlessness," and
this frequency also has not increased after the introduction of an SEP. Id.
21. Ricky N. Bluthenthal, Sterile Syringe Access Conditions and Variations in HIV Risk
Among Drug Injectors in Three Cities, 99 ADDICTION 1136, 1137 (2004) (blaming the lack of
predictability in syringe access between states on the fact that there is no "national policy"). It
was not until 2009 when President Obama signed the Consolidated Appropriations Act of
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left the burden of funding programs entirely to the states and private funders
for the next two decades.2 2
In 2009, as part of his National HIV Strategy, 23 President Obama modified
the ban on federal funds for SEPs when he signed the Consolidated
Appropriations Act of 2010.24 However, the federal government failed to
allocate funding for SEPs, and existing programs continued to face
significant barriers to obtaining resources.2 5 Ultimately, Congress reinstated
the ban in 2011 as part of its spending plan through fiscal year 2012.26
To achieve the goal of an AIDS-free generation, the U.S. must support
SEPs legally and financially. Part I provides background on HIV
transmission among IDUs and evidence supporting the use of SEPs to curb
HIV transmission in this population.27 Part II examines state and federal laws
and policies that create legal barriers to effective SEP implementation. 28 Part
III discusses the shortcomings of President Obama's modified ban and
proposes alternative language. 29 Finally, Part IV recommends specific legal
and policy changes regarding explicit authorization of SEPs-necessary to
achieve an AIDS-free generation.30

2010, that the federal government expressed any support for syringe and needle exchange
programs. Consolidated Appropriations Act of 2010, Pub. L. No. 111-117, § 505, 123 Stat.
3034, 3279 (2009).
22. Public Health Service Act, 42 U.S.C. § 300ee (2012). This Act states:
The purpose of [Subchapter XXIII. Prevention of Acquired Immune Deficiency
Syndrome,] is to provide for the establishment of education and information
programs to prevent and reduce exposure to, and the transmission of, the etiologic
agent for acquired immune deficiency syndrome . . . [but] [n]one of the funds
appropriated to carry out this subchapter may be used to provide education or
information designed to promote or encourage, directly, ... intravenous substance
abuse.
Id. § 300ee(a), (c); see also Thirty Years of America 's Drug War, supra note 6.
23.
WHITE HOUSE OFFICE OF NAT'L AIDS POL'Y, NATIONAL HIV/AIDS STRATEGY FOR
THE UNITED STATES (2010), available at http://www.whitehouse.gov/sites/default/files/

uploads/NHAS.pdf.
24. Consolidated Appropriations Act § 505.
25. Traci C. Green et al., Life After the Ban: An Assessment of US Syringe Exchange
Programs' Attitudes About and Early Experiences With Federal Funding, 5 AM. J. PUB.
HEALTH e9 (2012). Only three programs received federal funds, and the money did not help
to create new legally authorized programs or to enable existing programs to expand services.
Id. at ell.
26. Consolidated Appropriations Act of 2012, Pub. L. No. 112-74, § 523, 125 Stat. 786,
1115 (2011).
27. See discussion infra Part I.
28. See discussion infra Part II.
29. See discussion infra Part III.
30. See discussion infra Part IV.
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II. EVIDENCE-BASED HIV PREVENTION FOR INJECTING DRUG USERS

Sharing hypodermic needles, syringes, and other drug devices can transmit
HIV among IDUs. Injection drug use remains an important mechanism for
HIV transmission in the United States, with disproportionate impact on
women and minorities. However, as detailed below, SEPs have proven
effective in reducing the risk of HIV transmission among IDUs.
A HIV Transmission by Injecting Drug Users
HIV transmission among IDUs begins when drug users share hypodermic
needles, syringes, and other drug devices. 3' "Needle sharing" may transfer
bodily fluids and blood contaminated with HIV, or other infectious diseases
such as hepatitis and syphilis. 3 2 When a user injects drugs into a vein or
muscle, a small amount of the user's blood is deposited back into the needle.33
If the needle is shared with another IDU, the residual blood-potentially
infected with HIV-is injected into that person's bloodstream, easily
transmitting the virus.34 In addition to sharing needles, IDUs can transmit
blood between users who share other drug-related equipment.35
In addition to increasing the risk of HIV transmission between IDUs,
injecting drug use greatly increases the risk of infection for individuals
otherwise not considered at risk, such as heterosexual sex partners of IDUs,
children of mothers who are IDUs, or heterosexual sex partners of IDUs.3 6
Div. OF HIV/AIDS PREVENTION, CTRS. FOR DISEASE CONTROL & PREVENTION, HIV
WOMEN 1-2 (2011), available at http://www.cdc.gov/hiv/topics/women/pdf/
women.pdf; Div. of HIV/AIDS Prevention, AIDS Associated with Injecting-Drug Use, supra
note 14; Des Jarlais, supra note 15, at 1441; A. Grigoryan et al., HIV Infection Among
Injection-Drug Users-34 States, 2004--2007, 58 MORBIDITY & MORTALITY WKLY. REP. 1291
(2009); Access to Sterile Syringes, supra note 15.
32. Lawrence 0. Gostin, The Interconnected Epidemics of Drug Dependency and AIDS,
26 HARv. C.R.-C.L. L. REV. 113, 115, 117 (1991); Access to Sterile Syringes, supra note 15.
33. HIV Transmission,
CTRS.
FOR
DISEASE
CONTROL
&
PREVENTION,
http://www.cdc.gov/hiv/resources/qa/transmission.htm (last modified Mar. 25, 2010).
34. Gostin, supra note 32, at 115-16; HIV Transmission, supra note 33.
35. HIV Transmission, supra note 33. Other drug-related equipment that can transmit
blood includes "spoons" and "cookers" designed to dissolve drugs in water, cotton filters used
to remove particles from the drug solution, and unclean water used to rinse syringes after their
use. Id.; see also Why is Injecting Drug Use a Risk for HIV Transmission?, AIDSMAP,
http://www.aidsnmp.com/Why-is-injecting-drug-use-a-risk-for-HIV-transmission/
page/1324128/ (last visited Mar. 7, 2013).
36. Div. of HIV/AIDS Prevention, AIDS Associated with Injecting-Drug Use, supra note
14; Gostin, supra note 32, at 117. Heterosexual partners of IDUs and their children are labeled
"non-risk" groups but for their contact with IDUs. Id. ("Nearly seventy-two percent of all
heterosexual cases of AIDS reported in the United States involve persons who have had sexual
31.

AMONG

contact with an [IDU].... Seventy-nine percent of all children born infected with HIV have a
mother who either was an [IDU] or had sexual relations with an [IDU]."). Id. Importantly,
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Transmission to individuals without risk behaviors creates opportunities for
HIV to spread further into the general population.3 7 This "bridging" from
IDUs to the greater population poses a significant risk of new HIV infections
that makes prevention of HIV transmission among IDUs even more critical.3 8
B. Populations Affected by Injecting Drug Use and HIV
The CDC identified IDUs as one of the primary "transmission categories"
for contracting HIV.3 9 Although the number of new HIV infections among
IDUs has declined since the early 1990s, 0 IDUs still account for nearly onefifth of all HIV cases nationally."

sexual partners of IDUs may not be aware of their partner's drug use and, thus, may not
appreciate their own HIV risk. In addition, an estimated 20% of people infected with HIV are
unaware of their infection. Div. OF HIV/AIDS PREVENTION, CTRS. FOR DISEASE CONTROL &
PREVENTION,
HIV
IN
THE
UNITED
STATES
(2011),
available
at
http://www.cdc.gov/hiv/resources/factsheets/PDF/us.pdf. People may not take advantage of
HIV prevention measures if they are unaware of their HIV risk.
37. Don C. Des Jarlais, Preventing HIV Transmission Among Injecting Drug Users
(IDUs) and From IDUs to Noninjecting Sexual Partners in Sichuan, China, 34 SEXUALLY
TRANSMITTED DISEASES 583, 583-84 (2007). A "generalized epidemic" is present "where HIV

infection is transmitted primarily through heterosexual activity and 1% or more of the adult
population is infected." Id. at 583. HIV transmission through needle sharing is a risk factor
only for those who use hypodermic needles and syringes, thus creating an isolated HIV
epidemic. Id. However, when an HIV-infected IDU has sex with a non-IDU sexual partner,
this could introduce HIV into the general non-IDU population. Id.
38. Id.at584.
39. Div. OF HIV/AIDS PREVENTION, CTRS. FOR DISEASE CONTROL & PREVENTION, HIV IN
THE UNITED STATES (2011), available at http://www.cdc.gov/hiv/resources/factsheets/

PDF/us.pdf. The CDC estimates that injection drug users account for 9% of new infections
that occur each year in the United States. Id. at 2.
40.
CTRS. FOR DISEASE CONTROL & PREVENTION, AIDS DIAGNOSES AND DEATHS OF
PERSONS WITH AIDS, WITH INFECTION ATTRIBUTED TO INJECTION DRUG USE, 1985-2008-

UNITED

STATES

AND

DEPENDENT

AREAS

(2008),

available

at http://www.cdc.gov/

hiv/topics/surveillance/resources/slides/trends/slides/trends 1 .pdf. IDU-associated AIDS
diagnoses rose to almost 25,000 in 1993. Id. Since then, the number of IDU-associated AIDS
diagnoses has declined steadily each year, hovering just over 5,000 in 2008. Id.
41.

CTRS. FOR DISEASE CONTROL & PREVENTION, HIV IN THE UNITED STATES (2011),

available at http://www.cdc.gov/hiv/resources/factsheets/PDF/us.pdf. This represents a
decline from 2002, when approximately 36% of the cumulative cases in the United States were
attributed to IDUs. CTRS. FOR DISEASE CONTROL & PREVENTION, DRUG-ASSOCIATED HIV
TRANSMISSION
CONTINUES
IN THE
UNITED
STATES
(2002),
available
at

http://www.cdc.gov/hiv/resources/factsheets/PDF/idu.pdf

[hereinafter CTRS. FOR DISEASE

CONTROL & PREVENTION (2002)]. The decline is attributed in part to the success of SEPs and

other prevention measures. Salaam Semaan et al., Potential Role of Safer Injection Facilities
in Reducing HIV and Hepatitis C Infections and Overdose Mortality in the United States, 118
DRUG & ALCOHOL DEPENDENCE 100, 101 (2011). In 2009, IDUs accounted for approximately

9% of new infections. Joseph Prejean et al., Estimated HIV Incidence in the United States,
2006-2009, 6 PLoS ONE e17502 (2011). These percentages would be higher if they included
women infected as a result of heterosexual contact with an IDU. Samuel M. Jenness et al.,
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HIV transmission through injecting drug use disproportionally affects
women and minorities. Injecting drug use and high-risk sexual behavior are
the two most common modes of HIV transmission among women. 2 More
than half of all HIV cases among women relate to injecting drug use. 4 3 In
2010 alone, approximately 15% of females diagnosed with HIV attributed

transmission of the virus to injecting drug use, compared to 7% of males.
HIV disproportionately affects African-Americans and Latinos regardless of
transmission mode.
These statistics make a strong case for investment in prevention strategies
for IDUs as part of the effort toward an AIDS-free generation. IDUs may
account for up to one-third of infections among certain populations. Failure
to include IDU-directed strategies may undermine important goals of the
Blueprint. As Fauci and Folkers state, "reducing HIV infections among
reproductive-age women . . . is essential to eliminate mother-to-child

transmission of HIV."4 6 Failing to address a major source of infection among
women may undermine such efforts. Similarly, underestimating IDUs' role
Heterosexual HIV and Sexual Partnerships Between Injection Drug Users and Noninjection
Drug Users, 24 AIDS PATIENT CARE & STDs 175 (2010). IDUs continue to represent a
significant risk group globally, accounting for approximately one-third of people living with
HIV outside of sub-Saharan Africa. Libby Topp et al., Fifteen Years of HIV Surveillance
Among People Who Inject Drugs: The Australian Needle and Syringe Exchange Program
Survey 1995 2009, 25 AIDS 835, 835 (2011) (citing UNAIDS 2008 Report on the Global
AIDS Epidemic).
42. Div. OF HIV/AIDS PREVENTION, supra note 31, at 1.
43. CTRS. FOR DISEASE CONTROL& PREVENTION (2002), supra note 41, at 1. As of 2000,
57% percent of all cases of HIV in women were associated with injecting drug use or sexual
contact with an HIV-infected IDU. Id. at 1. A small proportion of HIV transmissions result
from blood transfusions, receiving blood products or organs, and from mother to baby. HIV
Transmission, supra note 33.
44. Ctrs. for Disease Control & Prevention, HIV Surveillance in Injection Drug Users
(through 2010), http://www.cdc.gov/hiv/idu/resources/slides/ (last modified July 23, 2012).
45. While Hispanics/Latinos made up 15% of the U.S. population in 2006, this group
accounted for 17% of new HIV infections that year. DIV. OF HIV/AIDS PREVENTION, CTRS.
FOR DISEASE CONTROL & PREVENTION, HIV AMONG HISPANICS/LATINOS 1 (2010), available
at http://www.cdc.gov/hiv/hispanics/resources/factsheets/pdf/hispanic.pdf. In 2009, the rate
of new HIV infection among African American men was six and a half times greater than
white men and two and a half times greater than Hispanic/Latino men. DIV. OF HIV/AIDS
PREVENTION, CTRS. FOR DISEASE CONTROL & PREVENTION, HIV AMONG AFRICAN AMERICANS
1 (2011), available at http://www.cdc.gov/hiv/topics/aa/pdf/aa.pdf; see also B. Laffoon et al.,
Disparities in Diagnoses of HIV Infection Between Blacks/African Americans and Other
Racial/Ethnic Populations-37 States, 2005-2008, 60 MORBIDITY & MORTALITY WKLY. REP.
93 (2011).
46. Anthony S. Fauci & Gregory K. Folkers, Towards an AIDS-Free Generation, 308
JAMA 343, 343 (2012).

47. While highly active antiretroviral therapy (HAART) during pregnancy can
substantially reduce the risk of transmission, it requires women to be aware of their infection.
See HHS PANEL ON TREATMENT OF HIV-INFECTED PREGNANT WOMEN AND PREVENTION OF
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in HIV infection may further exacerbate disparities in the populations most
affected by HIV. As discussed in the next section, SEPs are an important
component of prevention measures for IDUs.
C. Preventing the Spread of HIV
National efforts to provide education on HIV prevention techniques have
decreased the number of new infections since the epidemic began in the
1980's." Despite continued education on the modes of transmission and
means for prevention,4 9 risky behavior among IDUs continues, in part,
because of the lack of available clean syringes. 0 Recognizing that an IDU
may not be ready or able to stop using drugs, the CDC recommends using
clean or sterile drug equipment to avoid contact with HIV-infected blood.5
PERINATAL TRANSMISSION, RECOMMENDATIONS FOR USE OF ANTIRETROVIRAL DRUGS IN
PREGNANT HIV-1-INFECTED WOMEN FOR MATERNAL HEALTH AND INTERVENTIONS TO REDUCE
PERINATAL HIV TRANSMISSION IN THE UNITED STATES B-i (2012), available at
http://aidsinfo.nih.gov/guidelines/html/3/perinatal-guidelines/0/; see also MICHAEL A. SToTo
ET AL., REDUCING THE ODDS: PREVENTING PERiNATAL TRANSMISSION OF HIV IN THE UNITED
STATES 45, 47-50 (1999). HIV testing is recommended during pregnancy, but is not always

offered or accepted. Id. at 68. Moreover, IDUs may be less likely to access care. See generally,

Lesley Simmonds & Ross Coomber, Injecting Drug Users: A Stigmatised and Stigmatising
Population, 20 INT'L J. DRUGPOL'Y 121, 121 (2009). "In general, IDUs have poorer levels of
access to ART compared with non-IDUs, despite the fact that provision of [antiretroviral
therapy (ART)] to IDUs has population-wide health benefits and despite evidence that IDUs
can successfully undergo treatment and benefit from ART." WORLD HEALTH ORG. ET AL.,
WHO, UNODC, UNAIDS TECHNICAL GUIDE FOR COUNTRIES TO SET TARGETS FOR UNIVERSAL
ACCESS TO HIV PREVENTION, TREATMENT AND CARE FOR INJECTING DRUG USERS 6 (1999)
(citations
omitted),
available
at
http://www.unodc.org/
documents/hiv-aids/idu target settingguide.pdf.
48. NATIONAL CTR. FOR HIV/AIDS, CTRS. FOR DISEASE CONTROL & PREVENTION, HIV
PREVENTION IN THE UNITED STATES 2 (2009), available at http://www.cdc.gov/hiv/
resources/reports/pdf/hivprev us.pdf; see also H. Irene Hall et al., Estimation of HIV
Incidence in the United States, 300 J. AM. MED. Assoc. 520, 528 (2008). However, by the end
of 2006, one in five people infected with HIV still did not know their HIV status. HIV Testing,
CTRS.
FOR
DISEASE
CONTROL
& PREVENTION,
http://www.cdc.gov/hiv/topics/
testing/index.htm (last modified Feb. 27, 2013).
49. WHITE HOUSE OFFICE OF NAT'L AIDS POL'Y, supra note 23.
50. Des Jarlais, supra note 37, at 584. Despite their local success, SEPs in the United
States cannot meet the needs for clean injection equipment, reaching only an estimated 3% of
the IDU population. Semaan et al., supra note 41, at 104. A study in China demonstrated that
education alone is not enough to significantly decrease an IDU's risk for HIV transmission.
Joseph T.F. Lau et al., Clustering of Syringe Sharing and Unprotected Sex Risk Behaviors in
Male Injecting Drug Users in China, 34 SEXUALLY TRANSMITTED DISEASES 574 (2007). Over
80% of the study subjects correctly answered four out of five questions on modes HIV
transmission, but 35.7% of the subjects reported injecting with a syringe usedby another IDU
in the last 6 months. Id. at 575-76. These studies suggest that this discrepancy is because
"necessary materials (clean needles and syringes, condoms)" are not sufficiently available.
Des Jarlais, supra note 37, at 584.
51. Syringe Exchange Programs, CTRS. FOR DISEASE CONTROL & PREVENTION (Dec.
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However, IDUs inject drugs an estimated 1,000 times per year per person. 5 2
To comply with CDC recommendations, an average individual would need
to obtain 1,000 sterile syringes and needles each year. However, sterile
syringes and needles are not available in the quantities needed to actually
reduce risk.53 State and federal laws limiting or prohibiting the distribution
of syringes and needles prevent IDUs from receiving sterile equipment. 4
They also perpetuate the negative perception of IDUs as criminals rather than
persons with medical needs.55 Many states criminalize the possession of
hypodermic syringes and needles, 56 limit distribution by pharmacists and
2005), http://www.cdc.gov/idu/facts/aed-idu-syr.pdf. The recommendations include using
only new, sterile equipment; avoiding needle sharing; and purchasing syringes from a "reliable
source." Id. Several other government agencies and prevention organizations recommend
using sterile equipment to reduce the risk of HIV transmission in IDUs. See Access to Sterile
Syringes, supra note 15. For example, the Institute of Medicine of the National Academy of
Sciences published recommendations that for "injection drug users who cannot or will not stop
injecting drugs, the once-only use of sterile needles and syringes remains the safest, most
effective approach for limiting HIV transmission." Jennifer McNeely et al., Sterile Syringe
Access and Disposal Among Injection Drug Users Newly Enrolled in Methadone Maintenance
Treatment: A Cross-Sectional Survey, 3 HARM REDUCTION J. 8, 8 (2006) (quoting J. Normand
et al., executive summary of PREVENTING HIV TRANSMISSION: THE ROLE OF STERILE NEEDLES

AND BLEACH 2 (J. Normand et al. eds., 1995)). This approach, often referred to as "harm
reduction," recognizes the reality of drug use and addiction and seeks to minimize harms when
the underlying drug using behavior continues. See Canadian Paediatric Soc'y, Harm
Reduction: An Approach to Reducing Risky Health Behaviours In Adolescents, 13
PAEDIATRICS & CHILD HEALTH 53, 53 (2008) (describing history of harm reduction concept).

Addiction "is a chronic, relapsing disease, characterized by compulsive drug-seeking and use
and by molecular changes in the brain." Semaan et al., supra note 41, at 102.
52. P. Lurie et al., A Sterile Syringe for Every Drug User Injection: How Many Injections
Take Place Annually, and How Might Pharmacists Contribute to Syringe Distribution?, 18 J.
ACQUIRED IMMUNE DEFICIENCY SYNDROMES & HUMAN RETROVIROLOGY S45 (1998); see also

David Vlahov & Benjamin Junge, The Role of Needle Exchange Programs in HIV Prevention,
113 PUB. HEALTH REPS. 75 (1998); Access to Sterile Syringes, supra note 15.

53. Semaan et al., supra note 41, at 104; see also Larry Gostin et al., Prevention of
HIV/AIDS and Other Blood-Borne Diseases Among Injection Drug Users: ANational Survey
on the Regulation of Syringes and Needles, 277 J. AM. MED. Ass'N 53 (1997). Forty-seven
states and Washington, D.C. limit the availability of syringes and needles to zero when the
known use of these items is illegal injecting drug use. Id. at 54-55. Eight states have further
limited the sale of syringes and needles in pharmacies by requiring a doctor's prescription. Id.
at 56. See also discussion infra Part II.A.
54. Access to Sterile Syringes, supra note 15.
55.

INT'L FED'N OF RED CROSS & RED CRESCENT SOCIETIES, supra note 9, at 7. Stigma

creates a barrier to successful treatment and prevention for IDUs, both within the IDU
population and the greater community. Simmonds & Coomber, supra note 47, at 121. A
community may view an IDU with HIV as more "blameworthy" than an individual who
contracts HIV by more "innocent[]" means. Id. at 122.
56. Access to Sterile Syringes, supra note 15; see, e.g., ALA. CODE § 13A-12-260 (2012).
The term "drug paraphernalia" includes "[h]ypodernic syringes, needles and other objects
used, intended for use, or designed for use in parenterally injecting controlled substances into
the human body." Id. § 13A-12-260(a)(11). The Alabama code prohibits the possession, use,
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doctors, 7 and inhibit the operation of SEPs. 8 Stigmatizing and criminalizing
IDUs may prevent them from seeking or receiving medical services.59
Substance abuse behaviors make IDUs a unique at-risk population because
HIV prevention measures necessarily include treatment for the chronic
illness of addiction. 0 To the extent that the punitive approach to IDUs fails
to address mental health and addiction treatment, it fails to significantly
reduce IDU activity and resulting HIV transmissions.
The most effective prevention strategies take a comprehensive approach
to drug addiction and HIV prevention." SEPs seek to change risky
behavior-using unclean syringes and needles-while also addressing
substance abuse, thereby taking a more inclusive approach to the issues of
drug addiction and HIV prevention and treatment.62 Among other services,
delivery and sale of "drug paraphernalia." Id. § 13A-12-260(c)-(e).
57. Access to Sterile Syringes, supra note 15; see, e.g., CAL. Bus. & PROF. CODE § 4145
(2011). "[A] pharmacist may furnish or sell 10 or fewer hypodermic needles or syringes at any
one time to a person 18 years of age or older .... " Id. § 4145(a)(2).
58. Alexis N. Martinez et al., The Impact of Legalizing Syringe Exchange Programs on
Arrests Among Injection Drug Users in California, 84 J. URBAN HEALTH 423, 424 (2007);
Access to Sterile Syringes, supra note 15. Law enforcement plays an influential role in the
success or failure of a syringe exchange program. Martinez et al., supra, at 432. "Police
crackdowns" and "heightened street-level police intervention" are associated with decreased
syringe exchange participation. Without agreements with police, SEP activity may be viewed
as a reason to "crackdown," resulting in lower participation. Id.
59. Simmonds & Coomber, supra note 47, at 121.
60.

Definition of Addiction, AM.

Soc'Y OF ADDICTION MED.

(Apr.

19, 2011),

http://www.asam.org/for-the-public/definition-of-addiction.
"A particularly pathological
aspect of the way that persons with addiction pursue substance use or external rewards is that
preoccupation with, obsession with and/or pursuit of rewards (e.g., alcohol and other drug use)
persist despite the accumulation of adverse consequences. These manifestations can occur
compulsively or impulsively, as a reflection of impaired control." Id.
61. Access to Sterile Syringes, supra note 15. An effective comprehensive approach
requires a combination of substance abuse treatment and prevention to address the injecting
drug use, HIV treatment services, and access to sterile syringes and needles. DEP'T OF HEALTH
& HUMAN SERVS., IMPLEMENTATION GUIDANCE FOR SYRINGE SERVICES PROGRAMS 1 (2010),

available at http://www.cdc.gov/hiv/resources/guidelines/PDF/SSP-guidanceacc.pdf. The
prohibition of SEPs is unique to the United States, and such programs implemented in other
countries are effective in reducing needle-sharing behaviors, rates of HIV transmission, and
improving access to substance abuse treatment and prevention services. COMM. ON THE
PREVENTION OF HIV INFECTION AMONG INJECTING DRUG USERS IN HIGH-RISK COUNTRIES,

supra note 20; Lawrence 0. Gostin & Zita Lazzarini, Prevention of HIV/AIDS Among
Injection Drug Users: The Theory and Science of Public Health and Criminal Justice
Approaches to Disease Prevention, 46 EMORY L.J. 587, 676-80 (1997).
62.

DEP'T OF HEALTH & HUMAN SERVS., supra note 61. "The term SSP is inclusive of

syringe access, disposal, and needle exchange programs, as well as referral and linkage to HIV
prevention services, substance abuse treatment, and medical and mental health care." Id. The
WHO, UNODC, UNAIDS TECHNICAL GUIDE FOR COUNTRIES TO SET TARGETS FOR UNIVERSAL
ACCESS TO HIV PREVENTION, TREATMENT AND CARE FOR INJECTING DRUG USERS recommends

a comprehensive package for prevention, treatment and care of HIV among IDUs because the
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SEPs provide IDUs with a place to bring dirty and potentially infectious
injection equipment to exchange for clean, sterile replacements.6 3 The weight
of public health research consistently shows that programs facilitating dirtyfor-clean exchanges successfully curb the infection rate of blood-borne viral
illnesses in IDUs. The programs also create opportunities for addiction
treatment by offering recovery services, such as counseling, referral to
treatment centers, and connection with other medical resources in
conjunction with a syringe exchange."
interventions "have the greatest beneficial impact when delivered together." WORLD HEALTH
ORG. ET AL., supra note 47, at 7. The WHO's position is consistent with the scientific data.
Studies show that SEPs are "an effective way to link some hard-to-reach IDUs with important
public health services, including TB and STD screening and treatment. Through their referrals
to substance abuse treatment, SEPs can help IDUs stop using drugs. Studies also show that
SEPs do not encourage drug use among SEP participants or the recruitment of first-time drug
users." Syringe Exchange Programs, CTRS. FOR DISEASE CONTROL & PREVENTION (Dec.
2005), httu:/www cdc gov/idu/facts/aed idusyr df. Safe injection facilities offer services
similar to SEPs but also allow IDUs to inject at the facility. Studies show safe injection
facilities are "associated with use of drug treatment, health care, and social welfare services"
and "more rapid entry into detoxification programs" and result in less public injection and
litter in the neighborhood. Semaan et al., supra note 41, at 100, 102.
63. V. Guardino et al., Syringe Exchange Programs-United States, 2008, 59 MORBIDITY
& MORTALITY WKLY. REP. 1488, 1488 (2010) (defining SEPs); C.A. McKnight et al., Update:
Syringe Exchange Programs-United States, 2002, 54 MORBIDITY & MORTALITY WKLY. REP.
673, 673 (2005). Operations take place out of stores, mobile units, and in health clinics.
Syringe Exchange Programs, supra note 16.
64. SEPs can reduce HIV transmissionby 33-42% in some settings. For this reason, SEPs
are included in the "comprehensive package for the prevention, treatment and care of HIV
among IDUs." WORLD HEALTH ORG. ET AL., supra note 47, at 6. "An impressive body of
evidence suggests powerful effects from needle exchange programs . . . . Studies show
reduction in risk behavior as high as 80%, with estimates of a 30% or greater reduction of HIV
in IDUs." CTRS. FOR DISEASE CONTROL & PREVENTION, supra note 62 (quoting the 1997
National Institutes of Health Consensus Panel on HIV Prevention); Carol Strike et al.,
Guidelines for Better Harm Reduction: Evaluating Implementation of Best Practice
Recommendations for Needle and Syringe Programs (NSPs), 22 INTERNAT'L J. DRUG POL'Y
34, 34 (2011) ("Three decades of international evidence demonstrates that needle and syringe
programs (NSPs) reduce needle sharing, HIV incidence and prevalence, and are cost effective
when compared with the costs of treating individuals with HIV/AIDs.") (citations omitted).
See Ricky N. Bluthenthal et al., Higher Syringe Coverage is Associated with Lower Odds of
HIV Risk and Does Not Increase Unsafe Syringe Disposal Among Syringe Exchange Program
Clients, 89 DRUG & ALCOHOL DEPENDENCE 214, 219 (2007) (finding a "strong[] associat[ion]"
between the percentage of an individual's syringes obtained from an SEP and lower HIV risk);
Bluthenthal et al., supra note 21, at 1136 (describing programs that improve access to sterile
needles and syringes as "among the most effective methods for preventing the spread of
HIV . . . among injection drug users"); Margaret MacDonald et al., Effectiveness of Needle
and Syringe Programmes for Preventing HIV Transmission, 14 INT'L J. DRUG POL'Y 353
(2003); AlanNeaigus et al., Greater Drug Injecting Risk for HIV, HBV, and HCVInfection in
a City Where Syringe Exchange and Pharmacy Syringe Distribution are Illegal, 85 J.URBAN
HEALTH 309, 310 (2008) (reporting that most of the prior studies have found SEPs reduce the
risk of infection); J.M. Raboud et al., The Impact of Needle-Exchange Programs on the Spread
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Despite the evidence supporting SEPs as a prevention measure, SEPs face
strong opposition." Opponents express concern that supporting SEPs
excuses injecting drug use" and will increase the number of IDUs by creating
a network of known users. 7 In some states, "zero tolerance" policies for
drugs and drug paraphernalia allow no exceptions for even the most
compelling reasons-such as preventing transmission of life-threatening
diseases like HIV.68 Zero tolerance policies perpetuate tension between
health care professionals who consider IDUs to be patients, and law
enforcement officials who consider them to be criminals.69 Moreover, as
described further in Part II, any programs that do operate may do so at their
legal peril. 70

of HIV Among Injection Drug Users: A Simulation Study, 80 J.URBAN HEALTH 302 (2003)
(finding that while needle exchange programs, NEPs, are effective at reducing general risk,
the greatest impact of NEPs is on populations of "high-risk" IDUs); Abby E. Rudolph et al.,
Comparison of Injection Drug Users Accessing Syringes from Pharmacies, Syringe Exchange
Programs, and Other Syringe Sources to Inform Targeted HIV Prevention and Intervention
Strategies, 50 J. Am. PHARM. Ass'N 140 (2010) (finding IDUs more likely to use a new sterile
syringe for each injection when obtained from an SEP).
65. Semaanet al., supra note 41, at 103; David J. Merrill, Comment, Compassion for Drug
Addicts or Government-Sanctioned Drug Use?: An Overview of the Needle Exchange
Controversy, 23 PEPP. L. REv. 939, 941-42 (1996).
66. WILLIAM MARTIN, NEEDLE EXCHANGE PROGRAMS: SENDING THE RIGHT MESSAGE 10
(2009),
available
at
http://bakerinstitute.org/publications/DRUG-pub-MartinNeedle
ExchangeUpdate-011609.pdf; Gostin, supra note 32, at 132; Ban Lifted on Federal Funding
for Needle Exchange, supra note 19 (reporting that those criticizing the modification to the
ban fear that doing so provides incentives to continue drug use).
67. Martin T. Schechter et al., Do Needle Exchange Programmes Increase the Spread of
HIV Among Injection Drug Users?: An Investigation of the Vancouver Outbreak, 13 AIDS
F45, F49 (1999). However, this study found no evidence that participation in NEPs increased
needle sharing or risky behavior. See id.; see also Am. Found. for AIDS Research, Syringe
Exchange, BACKGROUNDER (June 2011), http://www.amfar.org/uploadedFiles/On The Hill/
SEPbackgrounder.pdf?n=3777; Joseph Guydish et al., Evaluating Needle Exchange: Are
There Negative Effects?, 7 AIDS 871 (1993).
68. See, e.g., State v. McCague, 714 A.2d 937, 944 (N.J. Super. Ct. App. Div. 1998); State
v. Sorge, 591 A.2d 1382, 1384-85 (N.J. Super. Ct. App. Div. 1991) (The state of New Jersey
"refuse[d] to treat as trivial the possession of even the most miniscule amounts of a controlled
dangerous substance," under the state's "zero tolerance drug policy."); Tempalski et al., supra
note 18, at 437-38 ("[T]he United States has been the historical leader in law enforcement and
abstinence-based approaches to illicit drug use .... ). However, there is little evidence that
an aggressive criminal law approach has "succeeded in reducing drug use, infectious diseases
in [IDUs], or overdose mortality of [IDUs]." Semaan et al., supra note 41, at 103.
69. Tempalski et al., supra note 18, at 437.
70. See infra notes 90-93 and accompanying text (discussing State v. McCague, 714 A.2d
937); Leo Beletsky et al., The Roles of Law, Client Race and Program Visibility in Shaping
Police Interference with the Operation of US Syringe Exchange Programs, 106 ADDICTION
357, 362 (2010) (concluding that "SEP authorization and laws governing syringe possession
do not influence substantially the frequency of police interference").

Published by LAW eCommons, 2013

13

Annals of Health Law, Vol. 22 [2013], Iss. 2, Art. 6

Vol 22, 2013

Annals of Health Law
ACHIEVING AN AIDS-FREE GENERATION

III. LAWS AND POLICIES CREATING BARRIERS TO

320

SEP IMPLEMENTATION

Several existing policies create barriers to SEP implementation, including
(1) state drug paraphernalia laws rooted in the federal War on Drugs and (2)
the federal ban on funding SEPs. This section explores how these policies
impede not only SEPs, but also the goal of an AIDS-free generation.
A State Laws Regulating Drug Paraphernalia,
Possession, Distribution, and SEPs
State statutes and regulations pose a significant barrier to clean syringe
and needle access." State regulation of syringe distribution and possession
began in Oregon, which passed the country's first drug paraphernalia law.72
The Oregon legislature based its statute on the U.S. Drug Enforcement
Administration's 1979 Model Drug Paraphernalia Act ("Model Act") .73 After
Oregon, thirty-seven additional states and Washington, D.C. also adopted
drug paraphernalia statutes based on the Model Act. 4
Only fourteen states, Washington, D.C., and Puerto Rico have laws that
explicitly authorize SEP operations.75 For example, California's statute

71. Access to Sterile Syringes, supra note 15.
72. See OR. REV. STAT. § 475.525 (2011). This statute prohibits the sale, delivery, and
possession of "drug paraphernalia." Id.; Non-Prescription Access, LAW, POLICY & PUBLIC
HEALTH AT TEMPLE UNIVERSITY'S BEASLEY SCHOOL OF LAW, http://www.temple.edu/
lawschool/phrhcs/otc.htm (last updated Nov. 28, 2008).
73. The Model Drug Paraphernalia Act states: "The term 'drug paraphernalia' means all
equipment, products and materials of any kind which are used, intended for use, or designed
for use, in . .. injecting .

..

. It includes, but is not limited to: . . . (11) Hypodermic syringes,

needles and other objects used, intended for use, or designed for use in parenterally injected
controlled substances into the human body .... " MODEL DRUG PARAPHERNALIA ACT (1979)
(full text of Model Act is published in Appendix B of United States v. Main Street Distributing,
700 F.Supp 655, 671 (E.D.N.Y. 1988)); Non-Prescription Access, supra note 72.
74. For a list of the thirty-seven states, see Steven E. Gersten, Drug Paraphernalia:
Illustrative of the Need for Federal-State Cooperation in Law Enforcement in an Era of New
Federalism, 26 Sw. U. L. REv. 1067, 1079 n.80 (1997).
75. California, Colorado, Connecticut, Delaware, Hawaii, Maine, Maryland,
Massachusetts, New Jersey, New Mexico, New York, Puerto Rico, Rhode Island, Texas,
Vermont, and the District of Columbia explicitly authorize SEPs. See CAL. HEALTH & SAFETY
CODE § 121349 (West 2012); COLO. REV. STAT. § 25-1-520 (2010); CONN. GEN. STAT. § 19a124 (2011); DEL. CODE ANN. tit. 29, § 7991 (2011); HAW. REV. STAT. § 325-112 (2012); ME.
REV. STAT. tit. 22, § 1341 (2011); MD. CODE ANN., HEALTH-GEN. §§ 24-802, 24-902 (West
2013); MASs. GEN. LAWS ch. 111, § 215 (1995); N.J. STAT. ANN. § 26:5C-27 (2012); N.M.
STAT. ANN. § 24-2C-4 (West 1997); N.Y. COMP. CODES R. & REGS. tit. 10, § 80.135 (1993);
P.R. LAWS ANN. tit. 24, § 2608 (2000); R.I. GEN. LAWS § 23-11-19 (2006); TEX. Gov'T CODE
ANN. § 531.0972 (West 2007); VT. STAT. ANN. tit. 18, § 4478 (1999); D.C. CODE § 48-1103.01
(2012). Although Washington does not explicitly authorize SEPs, it recently adopted
legislation that may implicitly authorize programs. See WASH. REv. CODE § 69.50.4121
(2012); see also Spokane Cnty. Health Dist. v. Brockett, 839 P.2d 324 (Wash. 1992)

https://lawecommons.luc.edu/annals/vol22/iss2/6

14

Hulkower and Wolf: Federal Funds for Syringe Exchange Programs: A Necessary Componen

Vol 22, 2013

Annals of Health Law
ACHIEVING AN AIDS-FREE GENERATION

321

provides: "In order to reduce the spread of HIV infection and bloodbome
hepatitis among the intravenous drug user population within California, the
Legislature hereby authorizes a clean needle and syringe exchange project."76
Additionally, eleven states have removed or abstained from adding
"hypodermic syringes, needles, and other equipment" to drug paraphernalia
laws." Absence of such language means that, in these eleven states, criminal
distribution and possession of "drug paraphernalia" may not include
hypodermic needles and syringes. However, SEPs in these states cannot rely
on the same strength of authority as an express authorization when battling
law enforcement." The remaining states include hypodermic syringes and
needles in their statutory definitions of drug paraphernalia, preventing SEPs
from operating legally without other authorization. 79
The decisions of the few courts that have addressed the legality of SEPs
are inconsistent.8 0 In 1992, in Spokane County Health District. v. Brockett,
(interpreting the Omnibus AIDS Act and other public health statutes as authorizing SEPs).
Interestingly, this list of states does not reflect the current epidemic. The states with the highest
rates of new AIDS diagnoses per year include Florida, Illinois, Pennsylvania, North Carolina,
and Georgia. HENRY J. KAISER FAMILY FOUND., THE HIV/AIDS EPIDEMIC IN THE UNITED
STATES 1 (2012), available at http://www.kff.org/hivaids/upload/3029-13.pdf.
76. CAL. HEALTH & SAFETY CODE § 121349(b). Section (a) of this statute contains
legislative findings and declarations in line with public health research findings that SEPs do
not increase or encourage drug use and are effective at reducing the spread of HIV. Id.
§ 121349(a).
77. The eleven states that have removed hypodermic syringes and needles from the
statutory definition of "drug paraphernalia" are Illinois, Michigan, Montana, Minnesota,
Nevada, New Hampshire, Oregon, Tennessee, Vermont, Wisconsin, and Wyoming. See 720
ILL. COMP. STAT. 600/2 (2012); MICH. Comp. LAWS § 333.7451 (1988); Minn. Stat. § 152.01
(2011); MONT. CODE ANN. § 45-10-101 (1981); NEV. REv. STAT. § 453.554 (1981); N.H. REv.
STAT. ANN § 318-B:1 (2013); OR. REv. STAT. § 475.525 (1995) (explicitly exempt from the
definition of paraphernalia); TENN. CODE ANN. § 39-17-402 (2012); VT. STAT. ANN. tit. 18,
§ 4475 (explicitly exempt from the definition of paraphernalia); WIS. STAT. § 961.571 (2012)
(explicitly exempt from the definition of paraphernalia); WYO. STAT. ANN. § 35-7-1002
(2011). Where that statutory description of "drug paraphernalia" is non-exclusive, a court
could still read it as covering hypodermic needles and syringes, although such an interpretation
would be weaker in those states where the legislature specifically removed the language, rather
than those that simply omitted them from the list.
78. Providing explicit authorization for an SEP reduces the amount of legal uncertainty
by removing the need for law enforcement officials to interpret the legality of such programs.
Providing an explicit authorization, rather than merely making SEPs "not illegal," limits law
enforcement officials' prosecutorial discretion in generally enforcing paraphernalia laws.
79. Non-Prescription Access, supra note 72; Dale Joseph Gilsinger, Construction and
Application of State Drug Paraphernalia Acts, 23 A.L.R.6th 307 (2007) (collecting cases and
laws).
80. Compare Spokane Cnty. Health Dist. v. Brockett, 839 P.2d 324 (Wash. 1992) (finding
that a needle exchange program aiming to prevent transmission of HIV between IDUs did not
violate drug paraphernalia laws), with Commonwealthv. Leno, 616 N.E.2d 453 (Mass. 1993)
(finding a necessity defense could not be awarded where defendants attempted to distribute
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the Spokane County Health District ("SCHD") sought a declaration on the
legality of an SEP proposed by its local Board of Health."' The SCHD Health
Board authorized the operation of an SEP in Spokane County, based on
Washington's Omnibus AIDS Act, which allows the Office on AIDS to
provide services for "intervention strategies specifically addressing groups
that are at a high risk of being infected with the human immunodeficiency
virus."8 2 The statute specifically identifies "needle sterilization" as a possible
strategy.83 However, even before the SEP began operating, Spokane County
Prosecuting Attorney Donald Brockett pledged to "take action" against the
operation." Brockett argued that distributing drug paraphernalia would
violate the state's Uniform Controlled Substances Act." The Spokane
County Superior Court found the program lawful." Reviewing the lower
court ruling, the Supreme Court of Washington recognized the apparent
conflict between the drug paraphernalia law and the establishment of an SEP,
but deferred to the legislature's public health goals-particularly its aim to
control the spread of HIV/AIDS." The Court relied on the Washington
legislature's "statement of intent" in promulgating the AIDS Act." The
legislature intended "to provide a program that is sufficiently flexible to meet
emerging needs," and thus the court interpreted the statute broadly, finding
the program lawful.8 9
On the other hand, in State v. McCague, a New Jersey state court found
defendants' operation of a syringe exchange violated state law prohibiting
possession and distribution of hypodermic needles and syringes.90 Using
private funds, defendants operated an SEP through a non-profit corporation,
though the program was affiliated with clinics at a state university. 91 The
sterile needles and syringes in an effort to prevent transmission of HIV among IDUs).
81. Spokane Cnty. Health Dist., 839 P.2d at 326.
82. WASH. REV. CODE § 70.24.400 (2010) (cited in Spokane Cnty. Health Dist., 839 P.2d
at 326-27).
83. Spokane Health Dist., 839 P.2d at 327.
84. Id.
85. Id. at 326-27. Washington's Uniform Controlled Substances Act was amended in
2012 to specifically exempt application to SEPs operated by public health or community HIV
prevention programs. WASH. REv. CODE § 69.50.4121(3), supra note 75.
86. Spokane Cnty. Health Dist., 839 P.2d at 328.
87. Id. at 328, 332; see also People v. Bordowitz, 588 N.Y.S.2d 507 (N.Y. Crim. Ct. 1991)
(finding the harm caused by HIV outweighed the harm in violating the statute, thus invoking
the medical necessity defense where defendants possessed sterile syringes).
88. Spokane Cnty. Health Dist., 839 P.2d at 330.
89.

Id. at 329.

90. State v. McCague, 714 A.2d 937 (N.J. Super. Ct. App. Div. 1998); see N.J. STAT. ANN.
§ 2C:36-6 (West 1999).
91. State v. McCague, 714 A.2d at 257-58.
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court refused to overturn defendants' convictions, citing New Jersey's "zero
tolerance" policy as a rigid standard for drug paraphernalia possession and
distribution that did not require a culpable mental state.9 2 Unlike the court in
Spokane County Health District, which relied upon the legislature's
statements in finding SEPs lawful despite the lack of express authorization
and the conflicting criminal statute, the McCague court did not discuss New
Jersey's public health stance or its public health statutes, perhaps because the
SEP was privately operated.
Drug paraphernalia laws remain an important barfier to legal operation of
SEPs. Federal funding alone will not change that. However, because these
laws spring from federal recommendations rooted in the War on Drugs,
federal policy affirming SEPs as a tool in the National HIV/AIDS Strategy
could influence the way states formulate or interpret their statutes. In
addition, Congressional endorsement of SEPs for preventing HIV could help
create a record for the public health rationale, similar to the effect that the
Washington legislature's statements had in Spokane County. Accordingly,
federal leadership authorizing and funding SEPs could contribute to the
pursuit of an AIDS-free generation. 93
B. The Ban On Federal Funding For Syringe And
Needle Exchange Programs
Consistent with federal anti-drug policies, Congress first banned federal
funding for SEPs in 1988. Except for a brief period in the first Obama
administration, the ban has been in place since 1988.94
1. Circumstances Leading Up to the Ban
When President Ronald Reagan entered office in 1981, he prioritized
Nixon's "War on Drugs." First Lady Nancy Reagan's anti-drug campaign,
"Just Say No," soon followed. 95 Following the Anti-Drug Abuse Act of 1986,
which created mandatory minimum sentencing guidelines for drug-related
convictions,96 and the Chemical Diversion and Trafficking Act of 1988,
92. Id. at 944; see also Commonwealthv. Leno, 616 N.E.2d 453 (Mass. 1993) (finding a
necessity defense could not be awarded where defendants attempted to distribute sterile
needles and syringes in an effort to prevent transmission of HIV among IDUs).
93. All three of the programs that received federal funds prior to the ban's reinstatement
were legally authorized. See Green et al., supra note 25, at eli. None of the unauthorized SEPs
received any state or federal funding. Id. at e10.
94. See Am. Found. for AIDS Research, supra note 67.
95. Thirty Years of America's Drug War, supra note 6.
96. See Anti-Drug Abuse Act of 1986, Pub. L. No. 99-570, 100 Stat 3207 (1986). This
Act outlined penalties for drug possession violations. For example, "[i]n the case of a
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which added airplanes and boats to the DEA'sjurisdiction,97 Congress passed
a ban on federal funding for SEPs. 98 The 1988 ban declared:
None of the funds provided under this Act or an amendment made by this
Act shall be used to provide individuals with hypodermic needles or
syringes so that such individuals may use illegal drugs, unless the Surgeon
General of the Public Health Service determines that a demonstration
needle exchange program would be effective in reducing drug abuse and
the risk that the public will become infected with the etiologic agent for
acquired immune deficiency syndrome. 99
This ban, written during the height of the HIV epidemic in the United States,
limited federal influence on HIV/AIDS prevention policy with respect to
IDUs and left it to the states, local governments, and private organizations to
craft responses to the epidemic. 0 0
2. The Modified Ban and Reinstated Ban
As part of his campaign during the 2008 presidential election, Senator
Barack Obama pledged to lift the twenty-one-year ban on federal funding for

violation ... involving I kilogram or more of a mixture or substance containing a detectable
amount of heroin ... such person shall be sentenced to a term of imprisonment which may not
be less than 10 years or more than life." 21 U.S.C. § 841(b) (2006), see also Thirty Years of
America 's Drug War, supra note 6.
97. See Chemical Diversion and Trafficking Act of 1988, Pub. L. No. 100-690, 102 Stat.
4312 (1988). In addition to adding registration requirements for aircrafts and boats, this Act
added the option of capital punishment for certain violations of the Anti Drug-Abuse Act of
1986: "[A]ny person engaging in an offense punishable under section 841(b)(1)(A) ... shall
be sentenced to any term of imprisonment, which shall not be less than 20 years, and which
may be up to life imprisonment, or may be sentenced to death." 21 U.S.C. § 848 (2006).
98. Health Omnibus Programs Extension of 1988, Pub. L. No. 100-607, § 256(b), 102
Stat. 3110 (codified as 42 U.S.C. § 300ee-5 (1988)). Peter A. Clark & M. Fadus, Federal
Funding for Needle Exchange Programs, 16 MEDICAL SCI. MONITOR PH 1 (2010).

99.
42 U.S.C. § 300ee-5.
100. On February 23, 2011, Vice Admiral Regina Benjamin, Surgeon General of the
United States Public Health Service, published her determination that a demonstration needle
exchange program would be "effective in reducing drug abuse and the risk of infection with
the etiologic agent for acquired immune deficiency syndrome." Determination That a
Demonstration Needle Exchange Program Would be Effective in Reducing Drug Abuse and
the Risk of Acquired Immune Deficiency Syndrome Infection Among Intravenous Drug
Users, 76 Fed. Reg. 10038-01 (Feb. 23, 2011). Vice Admiral Benjamin cited studies showing
that "SSPs are widely considered to be an effective way of reducing HIV transmission among
individuals who inject illicit drugs and there is ample evidence that SSPs also promote entry
and retention into treatment." Id. However, approving "demonstration" programs is not the
same as a large-scale endorsement of SEPs as part of a comprehensive HIV prevention
program.
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SEPs.'o' Although President Obama signed the Consolidated Appropriations
Act of 2010 after taking office,10 2 the act did not remove the rider provision
to lift the ban. Instead, the Act only modified the ban to say:
None of the funds contained in this Act may be used to distribute any
needle or syringe for the purpose of preventing the spread of blood borne
pathogens in any location that has been determined by the local public
health or local law enforcement authorities to be inappropriate for such
distribution.103
Thus, under the new bill, using federal funds to operate SEPs is allowed
unless local authorities determine the location is "inappropriate."
In response to the ban modification, the Department of Health and Human
Services ("HHS"), through CDC, published Implementation Guidance for
Syringe Services Programs as a template for organizations seeking federal
funding for SEPs.1o' This document outlined "guiding principles" for
grantees of federal funds, namely adherence to state and local laws and the
coordination of services for substance abuse and HIV prevention. 05
Interestingly, it also calls for affirmative documentation showing that local
law enforcement and health officials have approved the location of an SEP. 06
This last requirement shifts the statutory requirement from a restriction on
using funds where the location is deemed inappropriate, into a positive
eligibility requirement. This may make practical sense-perhaps the federal
government does not want to issue funds to an SEP only to have local
objections arise. 07 However, this shift also suggests more limited support for
101. See Am. Found. for AIDS Research, supra note 67; Ryan Grim, Obama Budget Bans
Federal Funding For Needle Exchange, Breaking Campaign Pledge, HUFFINGTON POST (June
7,
2009),
http://www.huffingtonpost.com/2009/05/07/obama-budget-bansfederal n 199436.html; Editorial, Righting a Wrong, Much Too Late, N.Y. TiMEs, Dec. 26,
2009, at A22.
102. Consolidated Appropriations Act of 2010, Pub. L. No. 111-117, § 505, 123 Stat.
3034, 3279; Richard C. Boldt, Drug Policy in Context: Rhetoric and Practice in the United
States and the United Kingdom, 62 S.C. L. REv. 261, 339 (2010); Ban Lifted on Federal
Funding for Needle Exchange, supra note 19.
103. Consolidated Appropriations Act of 2010 § 505.
104. DEP'T OF HEALTH &HUMAN SERVS., supra note 61.
105. Id. at 1-2.
106. Id. at 2.
107. The success of SEPs may also require cooperation with local law enforcement.
However, this recognizes the practical realities of the conflict between traditional criminal law
relating to drugs and drug use and public health goals. Leo Beletsky et al. surveyed 111 SEP
program managers (representing 59% of all SEPs), and a significant minority reported "client
harassment" by police (43%) and at least monthly, unauthorized confiscation of clients'
syringes (31%). Beletsky et al., supra note 70, at 359. They concluded that "legal status of
SEP, jurisdiction's syringe regulation environment and affiliation with health department were
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SEPs than the modification appeared to offer.
Some HIV prevention advocates and SEP supporters celebrated the
modification of the federal funding ban, taking it as a sign that the federal
government supports SEPs as a tool for HIV prevention, thus legitimizing the
practice. 08 However, other HIV prevention groups, such as the Harm
Reduction Coalition, argue that the modification did not go far enough to
make SEPs a legal reality at the national level.109 Only three of the 203 SEPs
recognized in the United States received federal funding under the modified
ban. 0 SEPs still cited a lack of stable funding as the most common problem

not associated with frequency of police interference." Id. at 357. Programs serving IDUs of
color experienced greater frequency of policy interference. Id. These results led the researchers
to conclude that "without targeted efforts to change police policies and practices on the local
level, formal legal reform alone may be insufficient to maximize the impact of SEPS and other
interventions targeting IDUs." Id. at 362. Additionally, "communication and coordination
between police and SEPs may reduce police interference, yielding improvements in overall
effectiveness and cost-effectiveness" of SEPs. Id. Working closely with law enforcement can
ninimize such problems. See Basha Silverman et al., Harmonizing Disease Prevention and
Police Practice in the Implementation of HIV Prevention Programs: Up-stream Strategies
from Wilmington, Delaware, 9 HARM REDUCTION J. 17 (2012).
108. Righting a Wrong, Much Too Late, supra note 101; Ban Lifted on Federal Funding
for Needle Exchange, supra note 19; In Wake of Syringe Ban Victory, CDC, Goosby
Contemplate
Future Funding, HOUSING WORKS BLOGS (Dec.
17, 2009),
http://www.housingworks.org/blogs/detail/what-the-end-of-the-syringe-exchange-banmeans/; see also Daniel Geyser, Needle Exchange Program Funding, 37 HARV. J. ON LEGIS.
265, 265 (2000) (commenting on the generally passive strategy the federal government has
taken to avoid a firm statement on its position on syringe and needle exchange programs,
focusing instead on funding for such programs).
109. Daniel Raymond, 194 Days and Counting: Syringe Exchange Is Working, So Why
Isn't the Administration Supporting It?, HUFFINGTON POsT (June 28, 2010),
http://www.huffingtonpost.com/allan-clear/194-days-and-counting-syr b 627949.html
("Bureaucratic inertia has repeatedly delayed the release of revised guidance from federal
agencies that would enable health departments and non-profit groups to apply their federal
dollars to syringe exchange. As states and local organizations continue to wrestle with their
own budget cuts, the lack of leadership and direction from the federal government has
paralyzed their efforts to plan, prioritize, and deliver services."); Letter from AIDS Action
Council, The Foundation for AIDS Research, Harm Reduction Coalition, National Alliance of
State & Territorial AIDS Directors, North American Syringe Exchange Network, Physicians
for Human rights, Open Society Institute, and Urban Coalition for HIV/AIDS Prevention
Services, to Jonathan Mermin, Dir., Div. of HIV/AIDS Prevention, Ctrs. for Disease Control
and Prevention (Mar. 5, 2010) (on file with author). The authors of this letter expressed
concern at requiring the involvement of law enforcement in granting permission for SEP
operation: "Community members and health officials have raised concerns about how federal
agencies will interpret this language, given both the diverse and complex histories of siting
negotiations for syringe access program and the complicated relationships between public
health, law enforcement, and syringe access." Id. at 1. "Syringe access is a public health
intervention, and thus properly falls under the jurisdiction of public health officials, and not
law enforcement." Id. at 2.
110. Green et al., supra note 25, at ell.
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they faced."' In fact, existing programs reported that without clearguidelines
on how the funds may be used, technical assistance from health departments,
and legal reform at the state level, lifting the ban was insufficient, and SEP
success required further affirmative authorization.11 2 Ultimately, the need for
permanent authority and funding became evident with the reinstatement of
the ban on SEP funding in December 2011.113
IV. THE FAILURE OF THE MODIFIED BAN
The Obama administration's attempt to modify the ban on federally

funding SEPs failed to achieve lasting change for two reasons: 1) its language
was confusing and 2) it did not affirmatively authorize SEPs.
A A Failure of Language
The language of the Consolidated Appropriations Act of 2010, modifying
the ban on using federal funds for SEPs, presents three problems that
perpetuate the legal barrier created by the original 1988 ban: 1) it uses
negatively-phrased language; 2) it distributes authority to both local public
health and law enforcement authorities; and 3) it does not define what
locations are "inappropriate" for SEPs.
None of the funds contained in this Act may be used to distribute any needle
or syringe for the purpose of preventing the spread of blood borne
pathogens in any location that has been determined by the local public
health or local law enforcement authorities to be inappropriate for such
distribution." 4
Use of negative language in the modified ban obfuscates what is actually
permitted.

The phrase "[n]one of the funds .

..

may be used ..

. in any

location" does not naturally lead to the inference that funding would be

allowed for SEPs.

Provisions that are designed to authorize funding in

appropriations bills generally use the language "shall be available" and
"funds are available." In contrast, this language could be read to mean that

111.

Id. at e9. The challenges for funding are not surprising given the effects of the

recession on resources, including state and local government budgets and the endowments of
private foundations. Semaan et al., supra note 41, at 103.
112. Green et al., supra note 25, at el5.
113. Consolidated Appropriations Act of 2012, Pub. L. No. 112-74, 125 Stat 786. The
prohibition was included in Division F, Title V, Sec. 523. Letter from Ronoldo 0. Valdiserri,
Deputy Assistant for the Sec'y of Health, Dep't of Health & Human Servs. (Mar. 29, 2012),
available at http://www.cdc.gov/hiv/resources/guidelines/PDF/SEC523.pdf.
114. Consolidated Appropriations Act of 2010, Pub. L. No. 111-117, § 505, 123 Stat.
3034, 3279 (emphasis added).
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funding is not available to any SEP unless it can qualify under an
exception." Indeed, as discussed in Part II, HHS took this approach in its
Guidance and required documentation that local public health authorities and
law enforcement approved a location as "appropriate." Congress could have
avoided this confusion with an affirmative statement (i.e., HHS shall or may
fund SEPs, except ...).16

Additionally, by granting authority to public health or law enforcement,
the modified ban created confusion about authority and responsibility for
SEPs. Specifically, the modified ban relied on local entities-"local public

health or local law enforcement authorities"11'-to determine which
locations were "inappropriate" for SEPs and, thus, ineligible for funding.
However, the fundamental challenge for SEPs is that the priorities of a public
health agency differ from those of local law enforcement. 11" The modified
ban's broad language not only fails to resolve this tension, but also
perpetuates it by dividing authority between these two groups without
providing a mechanism for balancing their competing priorities.
While public health agencies focus on the fight against HIV transmission
among IDUs, law enforcement agencies focus on the "fight against illegal
drug use."119 Studies suggest rigid law enforcement policies and a lack of
collaborative training between law enforcement and SEP promoters erodes
the efficacy of SEPs and deters participation.120 Gaps in state and local SEP
115. "Where Congress explicitly enumerates certain exceptions to a general prohibition,
additional exceptions are not to be implied, in the absence of a contrary legislative intent."
YULE KvI, CONGRESSIONAL RESEARCH SERVICE REPORT FOR CONGRESS, STATUTORY
INTERPRETATION: GENERAL PRINCIPLES AND RECENT TRENDS CRS-16-17 (2008) (quoting
Andrus v. Glover Const. Co., 446 U.S. 608, 616-17 (1980)).
116. For example, President Obama's Executive Order 13505, titled Removing Barriers
to Responsible Scientific Research Involving Human Stem Cells, repealed the ban on federal
funding for hESC research by providing, "The Secretary of Health and Human Services ... ,
through the Director of NIH, may support and conduct responsible, scientifically worthy
human stem cell research, including human embryonic stem cell research, to the extent
permitted by law." Exec. Order No. 13505, 74 Fed. Reg. 10,667 (Mar. 9, 2009).
117. Consolidated Appropriations Act of 2010 § 505.
118. For example, the mission of the Fulton County, Georgia, Department of Health and
Wellness is "to promote, protect and assure the health and Wellness of the people of Fulton
County." Health & Wellness, FULTON CNTY. Gov'T, http://www.fultoncountyga.gov/dhwabout (last visited Mar. 23, 2013). The mission of the Fulton County, Georgia, Police
Department is "to preserve life, protect property, and maintain order through a partnership
between

the

department

and

the

citizens."

FULTON

COUNTY

POLICE

DEP'T,

http://www.fultonpolice.org/ (last visited Mar. 23, 2013).
119. Steven R. Salbu, Needle Exchange, HIV Transmission, and Illegal Drug Use:
Informing Law and Public Policy with Science and Rational Discourse, 33 HARV. J.ONLEGIS.
105, 110 (1996). Some states attempt to write legislation authorizing SEPs within "potentially
hostile anti-drug laws." Id.
120. See generally Scott Burris et al., Addressing the "Risk Environment" for Injection
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policy give rise to the possibility of continued police confiscation of
hypodermic syringes and needles. Researchers predict an increase in arrests
as the visibility of SEPs increases.121 Yet law enforcement views can change
with better understanding of SEP operations.122 Moreover, as Spokane
County Health District 23 demonstrates, the endorsement of public health
authorities can tip the balance in favor of public health priorities when
conflicts arise with law enforcement, creating a more favorable environment
for SEPs.
Potential problems with the split authority between public health officials
and law enforcement are not simply theoretical. As indicated previously,
HHS's "Guiding Principles" for obtaining federal funding required
"documentation that local law enforcement and local public health
authorities have agreed upon the location for the operation of the [SEPs]." 24
HIV/AIDS advocacy organizations expressed concern about the
interpretation of this language because it requires public health and law
enforcement to agree about the location of an SEP when seeking federal
funding.125 In a letter to the Division of HIV/AIDS Prevention at CDC, eight
advocacy groups outlined issues with giving law enforcement organizations
a formal role in the decision-making process. 26 They argued that "syringe
access programs remain an arena governed by a delicate balance between
public health imperatives and law enforcement agendas." Public health
officials have authority over the programs, and giving law enforcement
Drug Users: The Mysterious Case of the Missing Cop, 82 MILBANK Q. 125 (2004); Jonathan
Cohen & Joanne Csete, As Strong as the Weakest Pillar: Harm Reduction, Law Enforcement
and Human Rights, 17 INT'L J. DRUG POL'Y 101 (2006); Zita Lazzarini et al., Evaluating the
Impact of Criminal Laws on HIVRisk Behavior, 30 J.L., MED. & ETHICS 239 (2002); Beletsky
et al., supra note 70; Silverman et al., supra note 107.
121. Silverman et al., supra note 107; Beletsky et al., supra note 70.
122. For example, Wilmington, Delaware's Police Chief was initially against the
initiation of SEPs:
[B]efore the pilot program was authorized, the Wilmington Police Chief spoke out
adamantly against the initiative: "No matter how you look at this issue, both sides
would have to agree that it boils down to putting clean needles in the hands of the
addicted so they can continue their illegal and dangerous activity."
Silverman et al., supra note 107, at 6. However, after two years of "relation-building efforts,"
the Police Chief changed his mind about the legality of SEPs. "My opinion of the program is
no longer relevant, but the success of this program is. . . . I'm committed to providing
leadership and cooperation from the law-enforcement end." Id. at 6 (alteration omitted). But
see generally Beletsky et al., supra note 70 (concluding that police activities still significantly
limit SEP operations).
123. See discussion supra notes 80-89 and accompanying text.
124. DEP'T OF HEALTH & HUMAN SERVICES, supra note 61, at 2 (emphasis added); see
also discussion supra Part II.A.
125. See Letter to Jonathan Mermin, supra note 109.
126. Id.
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officials a formal role in funding decisions "would jeopardize that delicate
balance." 27
The final problem with the language of the modified ban is its prohibition
on using federal funds for SEPs in locations deemed "inappropriate" without
defining the term "inappropriate" or "appropriate" in the statute or in the
HHS Guidelines.128 The House and Senate Joint Appropriations Committee
removed a proposed "1,000-foot Rule" 29 that would have prohibited
operation of an SEP within 1,000 feet of a public or private daycare center,
elementary school, vocational school, secondary school, college, junior
college or university; or within 1,000 feet of any public swimming pool, park,
playground, video arcade or youth center, or an event sponsored by any such
entity.'3 0 Although it severely limited possible siting for SEPs-especially
within urban environments-the 1,000-foot proposed rule is the only clue as
to appropriate location requirements.' 3 ' Given the lack of guidance, the
difference between "public health imperatives" and "law enforcement
agendas" could, again, result in varying definitions of an "inappropriate"
location for purposes of eligibility for federal funding.13 2
Because of these three problems with the language of the modified ban,
even if President Obama reinstated his modified provision into the
Consolidated Appropriations Act, its effectiveness as a tool for true SEP
promotion is limited. Additionally, as discussed in the next section, using the
appropriations process itself is unlikely to bring about the support for SEPs
that is needed to achieve an AIDS-free generation.

127. See id.
128. Consolidated Appropriations Act of 2010, Pub. L. No. 111-117, § 505, 123 Stat.
3034, 3279.
129. Darryl Fears, House Passes Bill that Lifts Ban on Using Federal Money for Needle
Exchanges,
WASH. PosT, July 25, 2009, http://www.washingtonpost.conVwpdyn/content/article/2009/07/24/AR2009072403632.htmil (noting that while the House Bill
removed the ban on federal funding for SEPs, a 1,000-foot rule would prevent SEPs in
Washington D.C. from operating in the city).
130. Ryan Grim, House Dems Reverse Obama, Remove Ban on Needle Exchange
Funding, HUFFINGTON PosT (Aug. 10, 2009), http://www.huffingtonpost.com/2009/07/10/
house-dems-reverse-obama n 22955 1.html. But "[t]his restriction is really designed to shut
down" needle exchange programs, rather than identify "appropriate" locations. Id.; see also
Mike Lillis, Congress Looks to Lift Two-Decade Ban on Federal Needle Exchange Funds,
WASH. IND. (July 31, 2009), http://washingtonindependent.com/53339/congress-looks-to-lifttwo-decade-ban-on-federal-needle-exchange-funds
(accusing
House
Appropriations
Chairman David Obey of including the ban to "appease conservative critics"). Id.
131. See Fears, supra note 129. As a practical matter, the 1,000-foot rule could have
prevented existing SEPs who operated within that boundary from obtaining federal funding
unless they relocated.
132. Letter to Jonathan Mermin, supra note 109.
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B. A Failure of Approach
An alternative approach could explicitly authorize funding for SEPs in the
appropriations bill. Other provisions in appropriations bills provide explicit
authorization for the use of federal funds.'33 By publishing a more explicit
authorization, Congress can clarify that the ban no longer exists. Such a
provision in the Consolidated Appropriations Act, phrased similarly to other
affirmative provisions in the Act, could read: "The Secretary of Health and
Human Services is authorized to make available funds to be used to distribute
any needle or syringe for the purpose of preventing the spread of blood borne
pathogens in any location."134
The proposed funding provision avoids the three problems identified in
the previous modified ban and sets the course for an affirmative program.
The affirmative phrasing portrays a distinctly different political intent from
the current SEP funding provision.135 The proposed provision also clearly
indicates that the HHS Secretary controls the fund dispersion. This minimizes
potential battles between local law enforcement and public health authorities.
Finally, the affirmative provision removes the arbitrary "appropriate
location" requirement.
This affirmative statement, explicitly authorizing SEPs, could become
federal law in the same way President Obama implemented the modified
ban-by inserting it into the appropriations bill. The benefits and drawbacks
of this approach become evident with a better understanding of the
appropriations process. The U.S. House and Senate Committees on
Appropriations have been in charge of authorizing federal spending since the
1860s.136 The Constitution requires that such appropriations begin in the
House of Representatives, and may be amended or approved by the Senate.137
Each year the committees assign, prohibit, and renew funding for federal
133. Consolidated Appropriations Act of 2010 § 505. For example, section 504
affirmatively enables funding "official reception and representation expenses" by the
Department of Labor and Education: "The Secretaries of Labor and Education are authorized
to make available not to exceed $28,000 and $22,000, respectively, from funds available for
salaries and expenses .... " Id. § 504 (emphasis added).
134. This proposed provision is based on the language appearing in similar appropriations
bill provisions. See id.
135. Consolidated Appropriations Act of 2012, Pub. L. No. 112-74, § 807, 125 Stat. 786,
941.
136.

See

About

the Committee,

U.S.

HOUSE

OF REPRESENTATIVES

COMM. ON

APPROPRIATIONS, http://appropriations.house.gov/About/ (last visited Mar. 18, 2013); see also
About

the

Committee,

U.S.

SENATE

COMM.

ON

APPROPRIATIONS,

http://www.

appropriations.senate.gov/about-history.cfm (last visited Mar. 18, 2013).
137. "All Bills for raising Revenue shall originate in the House of Representatives; but
the Senate may propose or concur with Amendments as on other Bills." U.S. CONST. art. I,
§ 7, cl. 1.

Published by LAW eCommons, 2013

25

Annals of Health Law, Vol. 22 [2013], Iss. 2, Art. 6

Vol 22, 2013

Annals of Health Law
ACHIEVING AN AIDS-FREE GENERATION

332

programs. 38 At the end of each fiscal year-typically September 30federally funded projects halt spending until a new appropriations bill
passes.'3 9 Because appropriations for federal funding always depend on the
yearly passage of a new bill, a certain amount of instability exists for
federally funded programs. "Riders," like the controversial SEP funding
provision, must survive from year to year.'
Looking at both the yearly renewal requirement for appropriations bills
and the inertia inherent in-passing bills in Congress, the appropriations
process may be the more politically expedient option for earning federal
funding for SEPs.'' However, for these same reasons, the appropriations
option is instable, as evidenced by the reinstatement of the ban in 2012.142 A
permanent, affirmative statement that the federal government supports SEPs
is necessary to encourage states to allow them.
V. THE NEED FOR EXPLICIT FEDERAL LAW SUPPORTING SEPs
The current federal position on SEPs creates a significant barrier to HIV
prevention and the achievement of an AIDS-free generation. The ban's brief
absence and subsequent reinstatement demonstrate why stronger
endorsement on a federal level is needed. The modified ban failed to improve
political and legal conditions for existing SEPs because it lacked teeth and
138. 63C AM. JUR. 2D Public Funds § 31 (2013).
139. Id. § 40.
140. An appropriations bill must originate in the House of Representatives, and, once the
House passes the bill, must be approved by the Senate. As indicated by the fact that Congress
has failed for fifteen consecutive years to pass an appropriations bill on time (the deadline is
October 1), it is no easy task. See Walter Alarkon, Another Omnibus Appropriations Bill Likely
as
the End of the Year Approaches,
THE
HILL (Nov.
12,
2009),
http://thehfill.conhomenews/house/67453 -another-omnibus-likely-as-appropriations-billsremain. A consolidated or omnibus appropriations bill combines several fiscal year
appropriations bills when one has not been passed as the end of the calendar year approaches.
Id.
141. The process of passing a bill can be arduous, and the solution is not politically
expedient. The challenges of passing legislation apply beyond the appropriations process. A
sponsoring Representative or Senator must first introduce the proposal, and, even if both
chambers of Congress vote to pass a bill, it must still survive presidential scrutiny. See
generally S. Doc. No. 105-14 (1997). In addition to the inherent inertia in the legislative
process, partisanship in today's Congress significantly limits the ability to move legislation
forward so much so that comparisons to Truman's "Do-Nothing Congress" abound. See, e.g.,
Amanda Terkel, 112th Congress Set To Become Most Unproductive Since 1940s, HUFFINGTON
PosT (Dec. 28, 2012,
9:37 AM), http://www.huffingtonpost.con2012/12/28/
congress-unproductive n 2371387.htmil.
142. The appropriations process may also make it less likely that a presidential
administration will fight for the provision. Support for funding of SEPs could jeopardize
funding for numerous other programs important to the administration, the federal govermnent
as a whole, and the public.
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permanence. Its quick reinstatement confirmed the need for more forceful
and lasting endorsement of SEPs. In support of the argument that the federal
government must act to legally and financially support SEPs, this Article first
looks to other ways the federal government has influenced local policy
through its own actions. It next considers what affirmative endorsement for
SEPs should look like.
A Lessons from Other Federal Funding Examples
The federal government has limited powers-primarily the authority to
tax, spend, and regulate interstate commerce enumerated in the
Constitution.' 4 3 The Tenth Amendment reserves all remaining powers to the
states. In particular, protection of public health is traditionally a state power.
Accordingly, the federal government cannot directly authorize or prohibit
policies for public health programs such as SEPs. However, it can and does
indirectly influence policy through funding decisions. 4 4 When Congress
banned federal funds for SEPs, it symbolically disapproved of the
programs.145 This position appeared to gain support when, in 1993, after
reviewing a University of California-San Francisco study declaring that SEPs
deserve federal funds, the CDC made no statement regarding federal funding.
Health officials interpreted the inaction as skepticism.' 46 President Obama
countered those positions when he modified the ban after promising support
for HIV prevention and SEPs. 4 1

143. LAWRENCE 0. GoSTIN, PUBLIC HEALTH LAW: POWER, DUTY, RESTRAINT 78 (2d ed.
2008).
144. Salbu, supra note 119, at 117 (observing that federal laws aim to control funding
[b]ecause direct public health policy traditionally falls within the states' police powers").
145. Congress banned funding for syringe and needle exchange programs in 1988, in the
wake of President Reagan's "War on Drugs." See Health Omnibus Programs Extension of
1988, Pub. L. No. 100-607, 102 Stat. 3048 (1988) (codified at 42 U.S.C. § 300ee-5 (2006)).
146. Salbu, supra note 119, at 117-19, 168-69 (reviewing federal actions and their
influence on the success of authorizing SEP).
147. See, e.g., Fears, supra note 129. AIDS advocate Ronald Johnson, who considered the
legislation to remove the funding ban, emphasized the "recognition by the federal government
of the proven cost-effectiveness and impact of syringe exchange as a very important tool for
prevention of HIV infection and viral hepatitis." Id. The CDC described the studies of costeffective as follows: "At an average cost of $0.97 per syringe distributed, SEPs can save
money in all IDU populations where the annual HIV seroincidence exceeds 2.1 per 100 person
years. The cost per HIV infection prevented by SEPs has been calculated at $4,000 to $12,000,
considerably less than the estimated $190,000 medical costs of treating a person infected with
HIV." Syringe Exchange Programs, supra note 16 (footnotes omitted). Similarly, President
Obama stated that his repeal of the ban on federal funds for human embryonic stem cell
research "restore[d] our commitment to science." President Barack Obama, Remarks at the
Signing of Stem Cell Executive Order and Scientific Integrity Presidential Memorandum
(Mar.
9,
2009),
available
at
http://www.
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Federal funding influences public health policy in a variety of ways. For
example, in the 1970s, the federal government allocated transportation funds
to states on the condition they change maximum highway speeds to fifty-five
miles per hour.14 Similarly, the federal government used funding incentives
to persuade states to adopt names-based HIV reporting.14 9
Coextensively, prohibitions on federal funding are common in
controversial areas of science and can have profound effects on a field.' The
federal ban on funding related to human embryonic stem cell ("hESC")
research demonstrates why explicit federal support for SEPs is necessary to
achieving an AIDS-free generation. Research on hESC is controversial
because, while it promises much in terms of scientific advancement, it
destroys human embryos.'"' Until 1993, federal regulations banned federal
whitehouse.gov/thepressoffice/Remarks-of-the-President-As-Prepared-for-DeliverySigning-of-Stem-Cell-Executive-Order-and-Scientific-Integrity-Presidential-Memorandum.
148. Emergency Highway Energy Conservation Act, Pub. L. No. 93-239, 87 Stat. 1046
(1974).
149. See Ctrs. for Disease Control & Prevention, Guidelines for National Human
Immunodeficiency Virus Case Surveillance, Including Monitoring for Human
Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome, 48 MORBIDITY
& MORTALITY WKLY. REP. 1 (1999) ("CDC will evaluate and award proposals for federal
funding of state and local surveillance programs based on their capacity to meet these
performance standards. At that time, CDC will require that recipients of federal funds for
HIV/AIDS case surveillance adopt surveillance methods and practices that will enable them
to achieve the standards to ensure that federal funds are awarded responsibly."); Letter from
Julie Louise Gerberding, Director of Ctrs. for Disease Control & Prevention, to Colleagues
(Jul.
5,
2005),
available
at
http://www.cdc.gov/hiv/pubs/070505
dearcolleaguegerberding.pdf (strengthening name-based surveillance from advice to a
recommendation, thus adding it to the list of performance standards established in 1999). Most
recently, the federal government sought to condition receipt of all state Medicaid funds on
expansion of Medicaid eligibility under the Patient Protection and Affordable Care Act. The
U.S. Supreme Court found this particular approach to be unconstitutionally coercive. Nat'l
Fed'n of Indep. Bus. v. Sebelius, 132 S. Ct. 2566, 2607 (2012).
150.

See CHRISTOPHER THOMAS SCOTT, STEM CELL Now: FROM THE EXPERIENT THAT

SHOOK THE WORLD TO THE NEW POLITICS OF LIFE 6-7 (2006); Paul Root Wolpe & Glenn

McGee, "Expert Bioethics" as Professional Discourse: The Case of Stem Cells, in THE
HUMAN EMBRYONIC STEM CELL DEBATE: SCIENCE, ETHICS, AND PUBLIC POLICY 190-92

(Suzanne Holland et al. eds., 2001); Edward A. Fallone, Funding Stem Cell Research: The
Convergence of Science, Religion & Politics in the Formation of Public Health Policy, 12
MARQ. ELDER'S ADVISOR 247 (2011). Politics, religion, and scientific research converge, and
the interests of conflicting interest groups have affected stem cell research using human
embryonic stem cells (hESC). Id. at 247. When AIDS first appeared in the United States in
the 1980s, politicians and scientists clashed over funding sources for vaccine research. Id. at
249. Similarly, controversy arose regarding public funding for promotion of condom use and
education. Id.; see also 0. Carter Snead, Science, Public Bioethics, and the Problem of
Integration, 43 U.C. DAVIS L. REV. 1529, 1532 (2010). Uncertain funding for stem cell
research is an example of the conflicts that occur when trying to satisfy both moral principles
and science, resulting in the dilemma of "public bioethics." Id.
151. Snead, supra note 150, at 1544.
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funding for any hESC research.152 Beginning with President Clinton's
administration in 1993, and continuing through subsequent administrations,
the status of federal funding reflects each Presidency's moral and ethical
views on hESC research.153 Under President Clinton, Congress repealed the
funding moratorium. Clinton's administration initiated an investigation, led
by the National Institutes of Health ("NIH"), to promulgate recommendations
on future funding.' 5 ' Before further funding was authorized, however, a
newly elected Republican Congress enacted the Balanced Budget
Downpayment Act, which prohibited funding for research that created or
destroyed human embryos. 55
President Clinton's Secretary of the Department of Health and Human
Services, Donna Shalala, attempted to work around this ban by determining
that it applied to the destruction of embryos, permitting federal monies to be
used for research on privately created cell lines. 5' However, even after
Secretary Shalala's announcement, few researchers applied for funds because
of the likelihood of a policy reversal.15' These fears were realized in 2001
when President Bush limited federal funding to the seventy-eight cell lines
existing at the time of his announcement. 58
152. Additional Protections for Pregnant Women, Human Fetuses and Neonates Involved
in Research, 45 C.F.R. § 46.204(d) (1982), repealed by National Institutes of Health
Revitalization Act of 1993, Pub. L. No. 103-43, § 121(c), 107 Stat. 122. The Ethics Advisory
Board (EAB) was required to annually approve funding for research involving human
embryos. Interestingly, the ban occurred because the EAB's charter expired in 1979 without
renewal, but the federal requirement of EAB funding approval remained. Snead, supra note
150, at 1545.
153. Snead, supra note 150, at 1545. Federal funds for scientific research are awarded or
withheld by the President, primarily through allotment to the National Institutes of Health. Id.
154. National Institutes of Health Revitalization Act of 1993, Pub. L. No. 103-43, 107
Stat. 122. Section 113(b) ensured federal fundingby requiringthat, "inthe case of any proposal
for research on the transplantation of human fetal tissue for therapeutic purposes, the Secretary
of Health and Human Services may not withhold funds for the research . . . ." Id. § 113(b).
This legislation further removed the EAB approval requirement for these funds. Id. § 121(c).
155. Balanced Budget Downpayment Act, I, Pub. L. No. 104-99, § 128, 110 Stat. 26, 34
(1996). The provision explicitly prohibited funding for "the creation of a human embryo or
embryos for research purposes; or [] research in which a human embryo or embryos are
destroyed, discarded, or knowingly subjected to risk of injury or death greater than that
allowed for research on fetuses in utero." Id. Congress "put teeth to the ban in the form of a
funding rider" renewed annually in the Appropriations Act. ScoTT, supra note 150, at 15354.
156. ScoTT, supra note 150, at 154.
157. Id. at 154-55. At the time NIH began soliciting proposal applications in 2000,
presidential candidate Governor George W. Bush promised to reverse the policy if elected. Id.
at 155.
158. Id. at 155. President Bush made a televised announcement on August 9, 2001, that
only research on existing cell lines could use federal funds. Id. In 2009, federal support shifted
back in favor of stem-cell research when President Obama lifted the ban on funding. See

Published by LAW eCommons, 2013

29

Annals of Health Law, Vol. 22 [2013], Iss. 2, Art. 6

Vol 22, 2013

Annals of Health Law
ACHIEVING AN AIDS-FREE GENERATION

336

As a result of the federal government's internal struggle to balance moral,
political, and scientific interests, the United States has fallen behind its global
counterparts in its stem-cell-based medical research.' 59 As Christopher Scott
explained, "No young scientist cares to pin his or her career ... on a subject
that could be outlawed at any moment."' 6 0 The long-term manipulation of
federal funding policies with each administration has created a chilling effect
that makes new scientists reluctant to enter the field and makes existing
organizations fear that they will unintentionally violate federal regulations.' 6 '
Because of the promise of hESC research, states stepped in to fill the
federal funding void, mitigating-but not eliminating-the effects of the
federal funding ban.162 States are less likely to fill the void in SEP funding,
in light of conflicting federal drug policies and the absence of strong federal
support. Indeed, as the evidence shows, state authorization of SEPs has been
impeded by a twenty-one-year ban on federal funding. Other also see a
Remarks of President Barack Obama, supra note 147 ("[W]e will lift the ban on federal
funding for promising embryonic stem cell research. We will vigorously support scientists
who pursue this research.").
159. Scholars discuss the repercussions only ten years later:
[T]he uncertain availability of federal funds for hESC research over the past decade
has slowed progress towards translating basic science into cures, has deterred
graduate students and other researchers from entering the entire field, and has
jeopardized the United States' leadership position in stem cell research versus our
global competitors.
Fallone, supra note 150, at 293. Aaron D. Levine, Identifying Under- and Overperforming
Countries in Research Related to Human Embryonic Stem Cells, 2 CELL STEM CELL 521, 523
(2008) (empirically examining the relationship between hESC policy and hESC research
publications and finding the United States "the largest underperformer by the metric used
here").
160. ScoTT, supra note 150, at 176 (discussing how instability and uncertainty among
federal funding policies for hESC research has stunted the progress of medical research in the
U.S.); see also Aaron D. Levine, Policy Uncertainty and the Conduct of Stem Cell Research,
2 CELL STEM CELL 521 (2008) (surveying U.S. stem cell scientists regarding effect of
uncertainty of funding following legal challenge to President Obama's lifting of ban on hESC
research funding on their research).
161. SCOTT, supra note 150, at 176; see also Sarah A. Webb, U.S. Embryonic Stem Cell
Research: Can Young Researchers Succeed?, SCIENCE CAREERS (Sept. 22, 2006),
http://sciencecareers.sciencenmg.org/career magazine/previous issues/articles/2006 09 22/
noDOI.649057395940566357. Because of the limitations placed on federal funding, before
2009 research facilities had to take extreme measures to ensure that research using federal
funds did not overlap with non-federally-funded activities. Id. In fear of violating a federal
law, researchers used separate equipment for federally funded research, and some research
organizations even built separate buildings for their federally funded work. Id. Separate
equipment and buildings is not feasible for all researchers, especially new operations that do
not receive enough money to afford duplicate operations. Id.
162. Aaron D. Levine, Research Policy and the Mobility of Stem Cell Scientists, 24
NATURE BIOTECHNOLOGY 865 (2006) (discussing impact of state hESC policies on mobility
of stem cell scientists).
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connection between the stem cell funding ban and the ban on federal funding
of SEPs. One author has called on President Obama to lift the prohibition,
stating, "While lifting a similarly boneheaded ban on stem cell research,
Obama issued a memo to agency heads, demanding, 'Science and the
scientific process must inform and guide decisions of my administration.'
Time to walk the talk, Mr. President."' 6 3
President Obama's own National HIV/AIDS strategy and his
administration's Blueprint for addressing the global HIV/AIDS pandemic
calls on science to guide federal investment. Given that the brief period under
the modified ban did little to facilitate SEP funding," and that only
seventeen jurisdictions have passed statutes authorizing SEPs, it is clear that
there is reluctance to operate such programs without federal support.' 5 A
different approach is warranted.
B. Explicitly Authorizing SEPs and SEP Funding by Statute
If President Obama's administration is serious about an AIDS-free
generation, it must support all the tools necessary to achieve it. Anthony
Fauci, Director of the National Institute of Allergy and Infectious Disease
("NIAID") recognizes the need for multiple approaches: "Achieving [the]
goal [of an AIDS-free generation], however, will require implementing a
multifaceted global effort to expand testing, treatment and prevention
programs, as well as meet the scientific challenges of developing an HIV
vaccine and possibly a cure."166 However, neither Fauci nor the Blueprint
include prevention strategies for IDUs in their plans of action. This critical
omission could undermine the ability to reach the goal. HIV/AIDS advocates
recognize the need for policies that address those populations
disproportionately affected by HIV, including IDUs, who are "most poorly

163. Kai Wright, Letting Science Lead, Again, RoOT (July 28, 2009),
http://www.theroot.conviews/letting-science-lead-again; see also Obama 's Budget Proposal
Expands HIV Prevention, Remains Silent on Syringes, AIDS FOUND. OF CHICAGO,
http://archive.aidschicago.org/advocacy/Obana Budget.php (last modified May 8, 2009).
164. During the few years before Congress reinstated the ban, SEPs reported that the lack
of infrastructure for implementing federal funding requirements continued to pose a significant
barrier for effectively receiving and using the funds. Green et al., supra note 25, at e14.
165. California is one of the fifteen states that have authorized SEPs. See CAL. HEALTH &
SAFETY CODE § 121349 (West 2012). The statute's legislative findings and declarations rely
on information from reports created by the federal government. See id. See also Tempalski et
al., supra note 18 (reviewing the influence of politics on public health policy decision-making
for SEP authorization as well as health policies of the past). Interestingly, California also
authorized stem cell research when the federal government did not. See CAL. CONST. art.

XXXV, § 5.
166.

Fauci & Folkers, supra note 46, at 344.
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served by both the existing prevention and medical systems."' The
challenge is in "connect[ing] the political will to the appropriations process.
Those are very big dots."' 68 Placing the political debate about authorization
and funding of SEPs within the context of the larger goal of achieving an
AIDS-free generation should make the request more palatable.
1. How to Authorize SEPs
The experience of funding through the appropriations process suggests the
need for a more permanent, affirmative method for expressing legal and
financial support for SEPs. As suggested in Part III, the language should
clearly express unequivocal support for SEPs as a prevention measure and
should explicitly authorize funding. To make the strongest impact for
SEPs,' 69 any such statement should be included as part of a national
HIV/AIDS-prevention and treatment program. The HIV/AIDS-prevention
community has already seen similar success with the Ryan White
Comprehensive AIDS Resources Emergency ("CARE") Act of 1990, which
provides essential support to HIV and AIDS patients throughout the United
States. Including SEPs in a comprehensive statute takes discretion out of the
hands of appropriations committees. Situating SEPs within the panoply of
available tools to combat HIV could also minimize political battles. Further,
passing a statute would also create a record showing that SEPs are a public
health necessity, much like the statements that were so useful in Spokane
County Health District.'
The Ryan White CARE Act exemplifies the strengths of an affirmatively
authorized funding program and provides a workable template for SEP
funding."' It provides federal funds for low-income, underinsured, and
uninsured people living with HIV, and their families. 7 2 The program also
167. John-Manuel Andriote, How Close Are We to an AIDS-Free Generation?, ATLANTIC
(2012), http://www.theatlantic.com/health/print/2012/12/how-close-are-we-to-an-aids-freegeneration/265857/ (last visited Mar. 23, 2013) (quoting Nancy Mahon, Global Executive
Director of the MAC AIDS Fund and chair of the Presidential Advisory Council on
HIV/AIDS).
168. Id. Stefano Bertozzi, M.D., Ph.D, director of the Bill and Melinda Gates
Foundation's HIV program, echoes Mahon's sentiments: "There is an opportunity to invest
more intelligently [ ] to make sure that we are investing in the most effective interventions and
make sure they are most focused on populations at greatest risk." Id.
169. For discussion of the expressive function of law, see Cass R. Sunstein, On the
Expressive Function of Law, 144 U. PA. L. REv. 2021 (1996); Richard H. McAdams, An
Attitudinal Theory of Expressive Law, 79 OR. L. REv. 339 (2000).
170. See discussion supra Part II.A.
171. Ryan White HIV/AIDS Treatment Extension Act of 2009 (Ryan White CARE Act),
Pub. L. No. 111-87, 123 Stat. 2885 (2009).
172. Health Res. & Servs. Admin., U.S. Dep't of Health & Human Sers., Legislation,
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funds service providers, based on geographic location, population need, and
services provided.' 73 The legislation is divided into "parts" to address a
comprehensive list of variable concerns for patients and providers"' and does
not rely on yearly appropriations approval. It provides a stable funding source
for programs. 175
Australia's experience further supports this approach. With bipartisan
political support, Australia established federally funded SEPs in 1986.176 The
government-funded SEPs are users' primary source of injecting equipment.
The low prevalence of HIV among Australian IDUs evidences the SEPs'
success.177
While affirmative federal legal and financial support for SEPs is essential
to achieving an AIDS-free generation, there are various political challenges
in achieving the necessary statutory change. Congressional opponents to
SEPs tried for many years to permanently ban the use of federal funds for
such programs by passing an independent statute. 171 Others in Congress
attempted to prevent prohibiting the use of federal funds for SEP operation
without success.179 In the current political climate, passing any statute is
HRSA HIV/AIDS
16, 2012).
173. Id.
174.

PROGRAMS,

http://hab.hrsa.gov/abouthab/legislation.htil (last visited Nov.

About the Ryan White HIV/AIDS Program, U.S. DEP'T OF HEALTH & HUMAN SERVS.,

http://hab.hrsa.gov/abouthab/aboutprogram.html (last visited Mar. 23, 2013). Part A provides
emergency assistance to areas that are most severely affected by HIV/AIDS; Part B establishes
grants for states; Part C addresses intervention services; Part F provides funds for a variety of
"Demonstration and Training" programs. See id.
175. President Bush reauthorized the Act in 2006 after extending it for one year when
Congress could not agree on changes to the Act during its 2005 reauthorization. Ryan White
HIV/AIDS Treatment Modernization Act of 2006, Pub. L. No. 109-415, 120 Stat. 2767 (2006);
see also HENRY J. KAISER FAMILY FOUND., TE RYAN WHITE CARE ACT: A SIDE-BY-SIDE
COMPARISON OF PRIOR LAW TO THE NEWLY REAUTHORIZED CARE ACT 1 (2006), available at

http://www.kff.org/hivaids/upload/ 7 531- 0 3.pdf. President Obama signed the Ryan White
HIV/AIDS Treatment Extension Act of 2009, extending the program for another four years.
Pub. L. No. 111-87, 123 Stat. 2885 (2009).
176. Topp et al., supra note 41, at 836.
177. Id. at 836, 837-38. Australian SEPs are "legal, relatively widespread and generally
accessible to the population of [IDUs]." Id. at 836, 840.
178. For example, in 1998, the House of Representatives passed a bill that would
permanently prohibit the use of any funds under any law from being used for the distribution
of needles and syringes. H.R. 3717, 105th Cong. (1998); see also H.R. 982, 106th Cong.
(1999) ("Notwithstanding any other provision of law, none of the amounts made available
under any Federal law for any fiscal year may be expended, directly or indirectly, to carry out
any program of distributing sterile needles or syringes for the hypodermic injection of any
illegal drug.").
179. In 2008, a bill "[t]o permit the use of Federal funds for syringe exchange programs"
was referred to the House Committee on Energy and Commerce but went no further. H.R.
6680, 110th Cong. (2008). The bill proposed that "nothing shall prohibit the use of Federal
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challenging, and it is not clear whether there is a lawmaker with the political
will and clout to advance the cause.'s IDUs typically do not have champions
in the houses of power. However, the goal of an AIDS-free generation is not
reachable without addressing the prevalence of HIV in the IDU community.
Affirmatively authorizing funding for the distribution of needles and
syringes for disease transmission prevention is the ideal solution for funding
problems facing SEPs. SEPs could operate under more stable funding
conditions if they are no longer funded through an appropriations bill. In turn,
this type of legislation sends a clear message to the states that the federal
government actively encourages SEPs. Perhaps then states will be
encouraged to change their drug paraphernalia statutes, recognize the realities
of a thirty-year epidemic, move past the failed War on Drugs, and authorize
SEP operations.
VI. CONCLUSION

Since the early 1980s, when scientists first discovered HIV,' the virus
has spread throughout the American population, resulting in an epidemic that
has caused over 500,000 deaths. 82 Public health professionals and
HIV/AIDS prevention advocates identify SEPs as an effective prevention
strategy. 83 Providing IDUs with a clean needle for every injection
significantly reduces the risk of transmitting HIV to another person.s 4
However, because SEPs are incompatible with the "War on Drugs," an
avoidable mode of transmission continues to spread the virus.
Efforts of law enforcement agencies-consistent with federal policy-

funds to establish or carry out a program of distributing sterile syringes." Id.
180. Until his death in 2009, Senator Edward Kennedy was considered the "champion of
social justice," proposing legislation to promote the needs of the general population, most
often in terms of health care reform. Arnold Schwarzenegger, Edward Kennedy, TIME (Apr.
30, 2009), http://www.time.com/time/specials/packages/article/0,28804,1894410_189384
7,00.html; see also Martin F. Nolan, Kennedy Dead at 77, BOSTON GLOBE (Aug. 26, 2009),
http://www.boston.com/news/local/massachusetts/articles/2009/08/26/kennedy-dead
at 77/?page=1 (calling Senator Kennedy the "'last lion' of the Senate"). However, it is not
clear that there is another "champion" to take Senator Kennedy's place.
181. See supra note 10.
182.
See supra note 11; see also HENRY J. KAISER FAMILY FOUND., THE HIV/AIDS
EPIDEMIC IN THE UNITED STATES 1 (2012), available at http://www.kff.org/hivaids/

upload/3029-12.pdf.
183. See supra notes 37-38; Access to Sterile Syringes, supra note 15. Legislation
attempting to authorize SEP funding also includes legislative findings. For example, House
Bill 6680 included findings that SEPs were successful in reducing HIV transmission and were
cost-effective, but did not increase the prevalence of illegal drug use or increase an IDU's drug
use. H.R. 6680, 110th Cong. (2008).
184. Guardino et al., supra note 63.

https://lawecommons.luc.edu/annals/vol22/iss2/6

34

Hulkower and Wolf: Federal Funds for Syringe Exchange Programs: A Necessary Componen

Vol 22, 2013

Annals of Health Law
AIDS-FREE GENERATION

341

ACHIEVING AN

discourage the distribution of drug paraphernalia for use with illegal drugs.
The punitive focus on drug users hinders policies that could reduce HIV
among IDUs.1 6 Federal support for SEPs has been politically controversial
and erratic. Federal policy regarding injecting drug use culminated in an
(almost) uninterrupted ban on the use of federal funding for SEPs since 1989.
This policy represents a significant barier to the President's stated goal of
achieving an AIDS-free generation. Without federal support, states have been
unwilling or unable to consistently support SEPs. Accordingly, the federal
government must act in unequivocal support for SEPs as part of a
comprehensive HIV prevention program, and provide funding to facilitate
prevention services for IDUs. Only with decisive federal funding and
guidance can an AIDS-free generation be realized.

185. See supra notes 65-69 and accompanying text. Law enforcement agencies operate
under a "zero tolerance" policy toward illegal drug use.
186. See supra notes 69-70 and accompanying text.
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